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In 1855 Addison described the disease which 
now bears his name and by post -mortem studies 
found that the adrenal glands were diseased. 
Publication of Addison's work stimulated Brown - 
Sequard (1856) to remove both adrenals from cats, 
dogs, rabbits and guinea -pigs. Death occurred 
within twelve hours, more rapidly than after 
removal of the kidneys, suggesting that the 
adrenal glands contained something which was 
essential to life. Removal of one adrenal alone 
was not sufficient to cause death. After a lapse 
of seventy years Rogoff and Stewart (1928) 
reported that the life span of adrenalectomized 
dogs could be prolonged by the administration of 
extracts of whole adrenals. These results were 
criticized by Swingle and Pfiffner (1931) who were 
the first investigators to demonstrate conclusively 
that a substance essential for the maintenance of 
life can be extracted with alcoholic benzene from 
the adrenal cortex. When a crude lipid fraction 
of the adrenal cortex was injected subcutaneously 
into bilaterally adrenalectomized cats the survival 
period of the cats was considerably prolonged. 
Gr:o.11man/ 
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Groliman and Firor (1932) found that a benzene 
extract of human urine also prolonged the life of 
adrenalectomized animals. 
Between 1935 and 1938 twenty one 
crystalline steroids were isolated from the 
adrenal cortex by Kendall, by Reichstein and by 
Wintersteiner and Pfiffner and the physiological 
activities of many of these substances were 
studied. From 1942 to 1946 it was shown by 
Dorfman and by Venning that urine extracts 
possessed similar physiological activities and 
the group of substances responsible for the 
activity was termed the 'cortin' fraction. The 
chemical behaviour and biological activity of this 
fraction suggested that it consisted of a mixture 
of compounds similar to those isolated from the 
adrenal cortex. This was confirmed when a 
crystalline ketone which reduced alkaline silver 
and increased the storage of glycogen in the liver 
was isolated from post -operative urine by Venning, 
Hoffman and Browne (1944). Conclusive evidence 
was provided by Mason and Sprague (1948) who isolated 
cortisol (11ß:17a:21-trihydroxy- pregn- 4- ene -3 :2O- 
dione) from the urine of a boy with Cushing's 
syndrome. Prior to this isolation a steroid with 
an/ 
an oxygen atom at position 11, typical of the 
adrenocortical compounds, 11 ketoetiocholanolone 
(3a- hydroxy -5p- androstane- 11:17 -dione) had been 
obtained from normal urine by Lieberman, Dobriner, 
Hill, Fieser and Rhoads (1948). This is a 
possible metabolite of cortisol but could also 
arise in other ways. In 1950 Schneider isolated 
from normal human urine cortisone (17a:2 1- dihydroxy,- 
i 
pregn- 4 -ene- 3:11 :20 -trione), tetrahydrocortisone 
(3a:17a:21- trihydroxy -5p- pregnane- 11:20- dione) 
and three other crystalline compounds. quali- 
tatively and quantitatively the amount of cortisonei 
isolated largely accounted for the activity of the 
cortin fraction in the liver glycogen assay. 
7ere it not for tao fortunate facts the 
isolation of cortisol and cortisone from urine 
and our knowledge of corticoid metabolism might 
have been delayed for some time. Unlike the male 
sex hormone or the pro g3 stational hormone, which 
only occur in urine in special conditions, the 
active hormones themselves normally occur in urine.' 
Testosterone has only been found in urine after its 
administration in large doses to humans and 
progesterone/ 
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progesterone has only been detected in pregnancy 
urine. Also the metabolites of testosterone and 
progesterone appear in the urine in a conjugated 
form and the free steroids were liberated by acid 
hydrolysis. Such hydrolysis destroys corticoids 
with a hydroxyl group at position 17 so that it 
was fortunate that cortisol and cortisone appear 
in urine in the unconjugated state. 
Fig. 1 shows the formula of a C -21 steroid. 
In the C -21 compounds the side chain has the ß 
configuration at C -17 and if a hydroxyl group is 
present at C -17 this has the a configuration. In 
the C -19 steroids the side chain at C -17 is absent 
and replaced by a hydroxyl group which then 
occupies the Í position or more often a ketone 




ill 13 C16 
C I 
C2 I CIO 9 8C 
14 
IS 
C34 C 6 C CSC 
Fig. 1. 
-5- 
Dorfman and Ungar (1953) have recently 
compiled tables showing all the C -19 and C -21 
steroids which have been isolated from natural 
sources but their tables have two defects; (1) 
no physical properties are recorded, and (2) the 
steroids listed in each table are not in any 
x 
order. Tables 1 and 2 show respectively the C -19 
and C-21 steroids listed in order of increasing 
oxygen content isolated from or identified in 
urine from humans whether normal, treated with 
adrenocorticotrophic hormone (ACTH) or with 
tumour or hyperplasia of the adrenal cortex. 
Compounds isolated after the administration of 
steroids are not included. Some of the compounds 
listed are artifacts produced during hydrolysis 
of conjugates. 
6p- Hydroxycortisol which was first isolated 
by Burstein, Dorfman and Nadel (1954) from the 
urine of a patient with Cushing's syndrome after 
the administration of cortisol has recently been 
isolated from normal human urine (Nadel, Burstein 
and Dorfman, 1956). Both the adrenals and the 
liver can hydroxylate steroids at the 6ß position 
but the significance of the reaction is not yet 
known/ 
x See Appendix II. 
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known. The 6p- hydroxy steroids synthesized by 
Ehrenstein and his co-workers had little activity. 
The two compounds 3a-hydroxy-5p- pregn- 16- en -20 -- 
one and 3p- hydroxy- androst- 5- ene -7 :17 -dione 
isolated by Fukushima, Kemp, Schneider, Stokem 
and Gallagher (1954) are possibly artifacts. The 
first could arise from a 16- hydroxylateq1 compound 
and it is known that 5 -ene steroids are capable of 
facile autoxidation at C -7 Pintersteiner and 
Bergstrom, 1941). Other steroids isolated from 
urine since the monograph of Dorfman and Ungar are 
commented upon later. 
Not the whole array of steroids found in urine 
are secreted as such by endocrine organs. Table 3 
lists those steroids which have been isolated from 
or identified in blood. In humans cortisol is 
quantitatively the main secretory product. The 
amount of corticosterone present seems very variable; 
some investigators have not detected any, others 
have found an amount equal to that of cortisol. 
Aldosterone, present in peripheral blood in minute 
amounts, appears to be responsible for about half 
i 
¡of the minera*orticoid activity of human blood. 
The isolation by Farrell et al. of 11- deoxycortico- 
sterone/ 
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Table 3. Steroids which have been isolated 
from or identified in blood. 
Authors 
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sterone (21 hydroxypregn -4- ene -3 :20- dione) proves 
that this steroid can be produced in vivo by the 
adrenal. Although originally isolated from the 
adrenal in small amounts by Reich.stein and von Euw 
(1938) it had subsequently only been detected on 
paper chromatograms of an adrenal extract and in 
perfusion experiments. It seems to be of little 
importance for it is present in very small amounts. 
nore recently the tetrahydro- derivative of 11- 
deoxycorticosterone has been isolated from the 
urine of a pseudohermaphrodite with adrenal hyper- 
plasia and hypertension by Eberlein and Bongio- 
vanni (1955). These investigators have also 
isolated 11- deoxycortisol (17a;21- dihydroxy- 
pregn- 4 -ene- 3:20 -dione) and its tetrahydro - 
derivative from the blood and urine of the same 
patient. The tetrahydro- compound which had 
previously been isolated from the urine of patients 
with adrenal carcinoma has now been isolated from 
normal urine (Touchstone, Bulashenko, Richardson 
and Dohan, 1955). Thus 11- deoxycortisol which 
has been isolated from dog adrenal vein blood may 
be a normal secretory product of the human adrenal. 
Several unidentified spots which give colour 
reactions/ 
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reactions typical of the steroids have been found 
on chromatograms of adrenal vein blood and it is 
known from in vitro work that the adrenal is 
capable of producing a large number of steroids. 
The nature and activity of these other components 
must await their isolation and certain identifi- 
cation. i.iany of the corticoids recently found in 
urine and blood have been identified only by their 
chromatographic properties and reactions and /or 
their infra -red spectrum. 
A recent important discovery has been the 
detection of steroid conjugates in human blood. 
Higeon and Plater (1954) could isolate dehydroepi.- 
androsterone from human plasma after acid hydrolysis 
but not after glucuronidase hydrolysis. Bongio- 
vanni (1954, Bongiovanni et al., 1954) found that 
after incubating serum, which had previously been 
extracted to remove free steroids, with a glucuroni- 
dase preparation more corticoids could be extracted. 
The steroid behaved chromatographically like tetra- 
hydrocortisone and approximately equal amounts of 
free and conjugated steroid were present. Thus 
the conjugated fraction must also be taken into 
account when determining plasma steroid levels. 
From/ 
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From the presence of certain steroids in urine 
and from the increased excretion of some of the 
compounds after administration of various steroids 
it is possible to deduce the reactions that occur 
in steroid metabolism. These are summarized 
briefly below: - 
(1) Ketone groups at positions 3 and 20 can be 
reduced to give both a and p isomers although the 
a appears to be the favoured position. Only 
compounds containing ß- hydroxyl groups have 
resulted from in vivo reduction of ketone groups 
in the 11 and 17 positions. However, 5(3- 
i 
androstane- 3a :17a --diol has been isolated from ox 
bile by Pearlman (1948) and 17a hydroxy compounds 
have been isolated from in vitro reactions. 
(2) Hydroxyl groups can be introduced at 
positions 17a and 21 in the C -21 steroids and at 
position 11p. Hydroxyl groups are also found at 
positions 6 and 16 in both configurations; 
whether these hydroxyl groups are introduced 
directly into the molecule as appears to be the 
case with 11p hydroxylation or whether they arise 
by reduction of ketone groups is unknown. 
Dorfman (1955) has reported that 16 keto- oestrone 
3 -/ 
-14- 
(3- hydroxy- oestra- 1 ;3 :5- triene- 16 :17- dione) has 
been isolated from normal female urine by Serchi 
(1953) and it has been shown that after adminis- 
tration to a normal male 16- keto -oestrone is 
reduced to oestriol. 6-Keto-progesterone 
(pregn- 4 -ene -3 :6:20- trione) has recently been 
isolated from perfusates of human placentae by 
Hagopian, Pincus, Carlo and Romanoff (1956). 
Hydroxyl groups may also occur at positions 2, 18 
and 19. 
(3) Hydroxyl groups at positions 3, 11 and, 
in C -19 steroids, at position 17 can be oxidized 
to ketone groups. 
(4) Double bonds at positions 1, 4 and 16 can 
be saturated and compounds of both the 5a and 5p 
series can be formed. 
(5) The 17- and 21 hydroxyl groups in C -21 
steroids can be removed forming 17- and 21- 
deoxy compounds. Since I!-arker and Lawson (1938) 
have isolated 5p- pregnan -3a -ol from pregnancy 
urine it is possible that the 20- hydroxyl group 
can also be removed. 
(6) The 5- en-- -3p -ol group can be converted to 
the 4-en-3-one group. 
(7) / 
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(7) The side chain of those steroids with a 
hydroxyl group at C -17 and a ketone group at C -20 
can be removed forming a 17 rketosteroid. 
It is estimated that the adrenal secretes 
between 15 mg. and 25 mg. of cortisol per day. 
It is imown that this arn.ount of cortisol or 
cortisone will maintain adrenalectomized patients. 
Dorfman (1954) estimated that 21 mg. per day of 
cortisol is secreted by the adrenal on the basis 
of the quantities of 1- -oxy- and l- deoxy -17- 
ketosteroids found in normal urine and the same 
value is suggested by Silber (1955) from a com- 
parison of the amount of phenylhydrazi ne- reacting 
substances in extracts of normal urine and in 
extracts of urine from persons injected with 
cortisone. Bondy and Altrock (1953) using an 
inaccurate riethod estimated the amount secreted to 
be between 15 mg. and 25 mg. per da-d. "recently 
Peterson and Wyngarden (1956) using cortisol -4 -C 
have found the turnover rate of endogenously 
synthesized cortisol to vary from 17 to 29 mg. 
per day and the average value for the subjects 
studied was 22 mg. per day. 
If these estimates are correct then we are now 
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cortisol secreted by the adrenal as urinary 
metabolites. After the administration of 
cortisol labelled with C14 to humans it has been 
shown that more than 80% of the radio- activity 
appears in urine during the first 24 hours and 
that after three days 95 of the administered 
dose is recovered from urine (Peterson and 7Tyn- 
garden, 1954). Fig. 2 depicts the possible 
metabolites of cortisol. For simplicity an 
abbreviated structural formula is used. The main 
metabolic reaction is reduction; thus one of the 
principal metabolites of cortisol is tetrahydro- 
cortisone and Baggett, Kinsella and Doisy (1953) 
have found the daily excretion of this compound 
to vary from 2 mg. to 7.4 mg. Following this 
reduction there is probably competition between 
further metabolism and conjugation with glucuronic 
acid and excretion. Reduction of the 20 ketone 
group produces both epimers - the a and ß cortols 
and cortolones. These are also excreted as con- 
jugates of glucuronic acid and the four compounds 
account for at least 30% of the metabolites of 
administered cortisol (Fukushima, Leeds, Bradlow 
Kritchevsky, Stokem and Gallagher,1955). Dihydro- 
cortisone/ 
-17- 
cortisone (17a;21- dihydroxy -5p- pregnane -3:11:20- 
trione) and tetrahydrocortisol (3a :11p:17a :21- 
tetrahydroxy- 5ç- pregnan -20 -one) are also found in 
urine and have been estimated by Cope and Hurlock 
(1953). Values quoted for the excretion of the 
above compounds must be minimal ones since in all 
cases the estimation was performed after enzymic 
hydrolysis which may not be complete and the 
compounds also have an appreciable water solu- 
bility which causes losses during the extraction 
procedures. 
Zondek and Finkelstein (1951, 1952, 1954) 
have found in urine a highly fluorogenic compound 
which has been shown to be the 21 -deoxy derivative 
of tetrahydrocortisone (3:17ä ;20a -trihydroxy -5p- 
pregnan -l1-one) by Finkelstein, von Euw and 
Reichstein (1953). The amount excreted by normal 
humans, measured after acid hydrolysis, varied 
from 0.75 mg. to 3 mg. per day. Cortisol and 
cortisone have long been known to occur in urine 
in small amounts, approximately 20 pg. to 100 pg. 
of each daily. From experiments in which 17- 
hydroxy -corticosteroids have been administered 
to adrenalectomized humans and by the use of 
radio -active steroids it appears that about 5% 
of/ 
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of cortisol or cortisone may be degraded to 17- 
ketosteroids. Rosselet, Jailer and Lieberman 
(1954) have demonstrated that the 17a hydroxyl 
group of a C -21 steroid can be re,uoved in vivo; 
after administration of 17a- hydroxypregn- 4- ene -3:2 
dione or 14:17a- dihydroxy- pregn- 4 -ene- 3:20 -dione 
to adrenalecto;:lized humans the 17 -deoxy derivatives 
were isolated in 0.2 ¡, and 1% yield respectively. 
Nadel, Burstein and Dorfman (1956) have found 
that 0.6 of fed cortisol is hydroxylated at the 
4 position. Table 4 summarizes the quantities 
of these metabolites found in normal urine; 
approximately 85 of the estimated production of 
cortisol can be accounted for agreeing well with 
the results of experiments with labelled cortisol. 
o 
Table 4 / 
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Table __ 4. Urinary excretion of cortisol 
metabolites; mg. per day. 
Tetrahydrocortisone 2 -7.4 
Cortols and cortolones appro.. 8 
Dihydrocortisone 0.2 -0.7 
Cortisol and cortisone 0.05 -0.2 
Sa;17a;20a- trihydroxy -5p- 
pregnan ---11 -one 0.75 -3 
Conversion to C -19 steroids 1 -1.5 
T;Iinor metabolic routes; - 
(a) 6p- hydroxylation 
(b) 17 -deoxy derivatives ) at least 0.5 
(c) Tetrahydrocortisol 
Total daily excretion 12.5 -21.3 mg. 
Estimated daily production of cortisol 15 -25 mg. 
In Fig. 2 those steroids surrounded by a dotted 
line have not yet been isolated from urine. 3a :17a- 
Dihydroxy -5(3- pregnane -11:20 -dione has been isolated 
only from the urine of a patient treated with ACTH 
(Lieberman, Katzenellenbogen, Schneider, Studer and 
Dobriner, 1953). 
The corticosterone secreted by the adrenal, 
unlike cortisol, cannot be accounted for as 
urinary metabolites. This is possibly due in 
part to the variable amounts of corticosterone 
secreted. Table 5 shows the metabolites of 
corticosterone/ 
-20- 
Table 5. Metabolites of corticosterone isolated 
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corticosterone or 11- dehydrocorticosterone that 
have been isolated from or identified in urine. 
Only one compound, 3ä:20a- dihydroxy -53- pregnan - 
11 -one, has been isolated from the urine of 
normal persons and this compound has not been 
found after administration of corticosterone or 
ACTH. Dyrenfurth and Venning (1955) have 
recently reported that they have detected cortico- 
sterone on chromatograms of extracts of normal 
urine. As with the 17- hydroxycorticosteroids 
reduction of ring A would appear to be a major 
metabolic reaction of the 17- deoxycorticosteroids 
and the tetrahydro derivatives of the 17- deoxy- 
corticosteroids may be found in the urine of 
untreated persons. However, it may be that the 
17- deoxycorticosteroids undergo reduction at C -21 
forming C 21 -deoxy compounds at a faster rate than 
the 17- hydroxycorticosteroids. Then under normal 
conditions when relatively small amounts of 
corticosterone are secreted the tetrahydro com- 
pounds of corticosterone end 11-dehydrocortico- 
sterone are predominantly reduced at C -21 whereas 
after administration of ACTH or corticosterone the 
increased amount of corticosterone is excreted 
mainly as the tetrahydro derivative. Compounds 
reduced at C -20 and /or C -21 would not have been 
detected/ 
-22- 
detected in the experiments of Dohan et al. since 
these workers were interested only in a- ketolic 
metabolites, nor would they be detected on paper 
chromatograms sprayed with the usual reagents. 
There is no evidence for the removal of an oxygen 
atom at position 11 or for the conversion of 17- 
deoxy compounds to 17-ketosteroids. It has been 
shown by Sandberg, Migeon and Samuels (1955) that 
after the intravenous injection of tort _coste.rone- 
4 -C14 to normal humans approximately 752° of the 
radio- activity appeared in the urine in 4° hours. 
Although during the past eight years we have 
learnt much about the metabolism of the steroids 
secreted by the adrenal cortex their mode of 
action is still unknown and little is known 
concerning possible interaction of the hormones. 
Hechter (1955) recently reviewed the evidence 
suggesting that the cortisol secreted by the 
adrenal is chanced into a more active form. 
Since then Wilson, Fairbanks, McJwen and Ziff 
(1955) have confirmed that cortisol is active 
when injected intra-articularly whilst cortisone 
is not. Paper chromatography showed that a number 
of metabolites were produced and they suggest that 
cortisol was active because it was transformed to 
a specific metabolic product. 
-23- 
PART I. A STUDY OF FORMALDEHYDOGENIC SUBSTANCES 
IN, AND THE ISOLATION OF CRYSTALLINE 




In 1951 Speirs and Meyer developed a bioassay, 
'specific for those corticosteroids with an oxygen 
atom at position 11 and a double bond at position 
4', based upon a decrease in the number of cir- 
culating eosinophils in adrenalectomized mice 
after injection of the assay material. Later 
Speirs, Wragg, Bonner and Homburger (1951) found 
that boiling urine at a neutral or slightly 
alkaline pH without loss of volume increased its 
activity compared with the unboiled urine. Boiling 
under acid conditions (pH 2) destroyed the activity. 
Marrian and Atherden (unpublished) showed that if 
urine which had previously been extracted with 
chloroform was boiled for half an hour the amount 
of formaldehydogenic substances (FSS)x which could 
be/ 
x Those substances which give rise to formaldehyde 
on periodate oxidation. Of the steroids only 
those with an a -ketol or a- glycol grouping so 
react. The determination of FSS is described 
in Part II. 
-25- 
be extracted by chloroform from the boiled urine 
was approximately equal to that extracted from 
unboiled urine. Colas (1955) showed by paper 
chromatography that extracts of boiled urine 
contained substances which would reduce blue 
tetrazolium and which were not present in extracts 
of unboiled urine. The substance present in 
largest amount was designated X and a second 
substance which was slightly more polar than X 
was termed Y. As described later X was trans- 
formed by acid into a compound termed Xa. From 
extracts of boiled urine Colas isolated in 
crystalline form a ketonic compound designated K2. 
Sections 3 -7 of this part of the thesis 
describe experiments carried out in collaboration 
with Dr A. Colas. Section 8 describes briefly 
the results obtained by Colas and summarizes the 
information concerning the substances under 
investigation which had been collected at the 
time that Colas completed his investigations. The 
remaining sections describe the further experiments 




(a) Extraction of urine. 
For the experiments described in Sections 3 
to 7 normal male urine, collected without preser- 
vative, was extracted with 2 vol. chloroform. The 
extracted urine was then boiled for 1 hr., cooled 
and reextracted with 2 vol. chloroform. The 
chloroform extracts were washed twice with 1/5 vol. 
0.1 N- sodium hydroxide solution, twice with 1/5 
vol. distilled water, dried over anhydrous sodium 
sulphate and evaporated to dryness in vacuo at a 
temperature about 6000. 
Two procedures have been used for extracting 
the larger amounts of urine needed for isolation 
work. In neither of them was the urine extracted 
before boiling. In the first the urine after 
having been boiled was extracted 4 times with 1 /10 
vol. chloroform and any emulsions formed were 
broken by centrifugation. In the second the urine 
was concentrated to 1 /10 of its original volume 
in a metal still, boiled for 1 hr. and extracted 
three times with a volume of chloroform equal to 
1/20 of the original volume of urine. The 




(b) Partition Procedure. 
Urine extracts which were to be chromatographed 
were purified by the following procedure. The 
crude residue left after evaporation of the chloro- 
form was dissolved in 10 ml. of 70 aqueous 
methanol (v /v) and the solution transferred to a 
small separating funnel containing 20 ml. hexane. 
The flask which had contained the urine residue 
was washed with another 10 ml. aqueous methanol 
and this was also transferred to the separating 
funnel. After shaking and equilibration the 
aqueous layer was removed. The hexane was re- 
extracted with 20 ml. aqueous methanol and the 
combined methanol extracts evaporated in vacuo 
until about 10 ml. of liquid remained. This was 
diluted with 10 ml. water and the solution 
extracted with 50 ml. of ether. The ether 
extract was dried over anhydrous sodium sulphate, 
filtered and evaporated to dryness in vacuo. The 
residue was transferred to a small tube and 
dissolved in methanol for chromatography. 
The above volumes are suitable for residues 
weighing not more than 25 mg. 
(c) Paper Chromatography. 
The solvent systems developed by Bush (1952) 
listed below have been employed. These were used 
at/ 
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at 18 °C. and were satisfactory without modification 
except for system B5. 
System A Light petroleum, methanol, water (10:8:2) 
Bl Light petroleum, 





B5 Benzene, methanol, water (10 :7:3) 
(modified) 
Solvent mixtures were renewed monthly. 
Whatman No. 42 chromatography paper was used. 
The material to be chromatographed was applied to 
the paper by means of a 0.1 ml. blood pipette 
calibrated in microlitres and with the tip drawn 
out into a fine capillary. The paper was held 
over a warm boiling plate and a measured amount of 
a methanolic solution of the residue to be 
chromatographed applied to the paper so that the 
resulting spot was less than 1 cm. in diameter. 
Development was allowed to take place until the 
solvent front was 8 -10 inches from the starting 
line when the paper was removed from the tank and 
allowed to dry in air. 
15 µg. amounts of pure steroids (either 
cortisol, cortisone or 11- deoxycortisol) were run 
as standards on each paper. 
Compounds containing an aß unsaturated ketone 
group/ 
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group were detected by the fluorescence reaction 
of Bush (1952) or by their adsorption of ultra- 
violet light of wavelength 253.7 mµ. a- Ketolic 
compounds were detected by their ability to reduce 
an alkaline blue tetrazolium (BT) solution (10 mg. 
BT dissolved in 10 ml. water; to this solution 
5 ml. of 10% sodium hydroxide solution are added). 
(d) Column Chromatography of eine Extracts. 
For the isolation of K2 the extract from the 
ether phase of the partition procedure was 
chromatographed on 60 g. of a 1:1 mixture of 
magnesium silicate and Celite (Schneider, 1950a,ó). 
This was made into a slurry with petroleum ether 
(boiling range 80- 100 °C.) and packed to form a 
column approximately 30 x 2.5 cm. The extract to 
be chromatographed, being insoluble in petroleum 
ether, was adsorbed onto a small amount of the 
magnesium silicate -Celite mixture which was packed 
onto the top of the column. Elution was performed 
by a modification of the gradient elution technique 
(Laksmannan and Lieberman, 1954) best described 
as discontinuous gradient elution. From a reservoir 
containing 1 litre of petroleum ether, 10 ml. were 
removed and poured onto the top of the column. Then 
2 ml. of ethanol were added to the reservoir, the 
mixture/ 
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mixture shaken and 10 ml. of this mixture next 
applied to the column. This process of removing 
10 ml. of liquid from the reservoir and adding 
2 ml. of ethanol was continued until 20 fractions 
of 40 ml. each had been collected. The rate of 
flow of eluate from the column was about 3 ml. 
per min. achieved by the application of positive 
pressure (about 6 cm. mercury) to the top of the 
column. The solvent was removed from each 
fraction by evaporation under a blast of air. An 
aliquot usually 1/200 of each alternate fraction 
was then chromatographed on paper in system B2 
and those fractions shown to contain X were com- 
bined. The residue containing X was then 
subjected to a Girard separation. 
The non -ketonic fraction resulting from the 
Girard separation and those fractions not contain- 
ing any X were combined and stored. The ketonic 
fraction obtained from the 2nd, 3rd and 4th pools 
of urine was then chromatographed on 10 g. of a 
1:1 mixture of magnesium silicate -Celite forming 
an 18 x 1 cm. column. The ketonic fraction was 
applied adsorbed on a small amount of the mixture 
and discontinuous gradient elution again used 
starting with 200 ml. petroleum ether in the 
reservoir, removing 10 ml. and adding 0.5 ml. 
ethanol/ 
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ethanol etc. 20 fractions each of 10 ml. were 
collected. An aliquot, usually 1/150 of the 
residue obtained from each alternate fraction,was 
chromatographed on paper in system B2 and those 
fractions shown to contain Xa were combined. In 
later work this second chromatography on magnesium 
silicate -Celite was omitted. 
The residue containing Xa was then subjected 
to partition chromatography using Celite as the 
supporting medium. The stationary phase was 80% 
aqueous methanol and the mobile phase was benzene. 
The phases were mutually saturated and the 
columns were prepared as described by Butt, Morris, 
Morris and Williams (1951) and Bauld (1955). 
Sixty grams of Celite mixed with 60 ml. of 
stationary phase were packed to produce a column 
32 x 2 cm. The residue containing Xa was 
dissolved in the smallest amount of stationary 
phase (usually 0.5 -1.0 ml.), the required amount 
of Celite added to adsorb the solution and the 
Celite packed onto the top of the column. Eighteen 
fractions of 25 ml. were collected, the flow rate 
being 40 ml. per hr. After removal of the solvent 
1/150 of alternate fractions were chromatographed 
on paper and those fractions shown to contain Xa 
were/ 
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were combined, the residue dissolved in methanol 
and filtered, to remove traces of Celite, into a 
small (10 -15 ml.) conical flask for crystallization. 
The average characteristics of the columns 
used are described below. The average weights of 
the fractions at various stages, an index of the 
purification achieved, are also shown assuming 
the volume of urine extracted to be 200 litres. 
Butt, Morris, Morris and Williams (1951) 
by modifying the general equation of Martin and 
Synge (1941) have derived a term Vr called the 
'retention' volume. This is the volume of eluate 
collected before the peak concentration of the 
solute emerges from the column. If the partition 
coefficient of the solute is zero the retention 
volume for this solute is equal to the dead volume 
VD of the column. These terms are useful for 
describing the characteristics of a column and 
the behaviour of a solute passing through the 
column. Since some of the pigments present in 
urine extracts usually have partition coefficients 
close to zero the dead volume recorded below 
denotes the eluate volume at which the front of 
the first pigment band appeared. Also since it 
is often difficult to determine when the peak 
concentration of any solute is leaving the column 
the/ 
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the term Vr used below denotes the volume of 
eluate collected before the first fraction 
containing any of the solute under consideration 
is collected. 
Volume of urine extracted 200 litres 
Wt. of residue from ether phase of partition 
procedure 1.2 -1.5 g. 
1st Column: 60 g. magnesium silicate -Celite 
VD 180 ml. Vr 250 ml. 
Wt. of X fraction 500 -600 mg. 
Wt. of ketonic fraction 160 mg. 
Wt. of non -ketonic fraction 250 -300 mg. 
2nd Column: 10 g. magnesium silicate -Celite 
VD 40 ml. Vr 80 ml. 
Wt. of Xa fraction 75 mg. 
3rd Column: 60 g. Celite 
VD 45 ml. Vr 150 ml. 
Wt. of Xa fraction 40-60 mg. 
(e) Girard separation 
To separate those compounds containing a 
ketone group from those not containing one a 
modification of the method first introduced by 
Girard and Sandulesco (1936) was used. The 
procedure is shown in Fig. 3 and is essentially 
the same as that described by Schneider(1952) for 
the isolation of corticosteroids from human urine. 
-34- 
Fig. 3. Girard Separation. 
1. Dissolve the crude fraction containing no more than 10 mg. 
of ketosteroids in 1 ml. of 50% (v /v) acetic acid in 90% 
(v /v) aqueous methanol. Add 100 mg. of Girard's reagent 
T and warm gently if necessary until complete solution. 
Leave the reaction mixture overnight at room temperature. 
. In the morning, add small pieces of ice and 10,ml. of ice - 
cold water. Transfer to a 50 ml. separating funnel. Add 
3 ml. of ice -cold 2.5 N -NaOH. The flask is washed with 
10 ml, of ice -cold water which are also transferred to 
the funnel. 
3, Extract eight times with 10 ml. of ice -cold chloroform, 
allowing the separation of the two phases to take place 
each time. Combine the chloroform extracts. 
A'UEOUS PHASE 
. Add 2 ml. of 5 ?. H2SO4 
and extract immediately 
with 10 ml. of chloro- 
form. Seven more ex- 
tractions with 10 ml, 
portions of chloroform 
are carried out in the 
course of two hours. 
Water pha s e 
discarded 
Chloroform extracts com- 
bined and washed as in (5) . 
The dry residue is the 
ketonic fraction. 
CHC13 PHASE 
5. Wash the combined 
chloroform extracts 
once with 115 ml. of 
0.25 N- Na2CO3 and 
three times with 




dried over anhydrous 
Na2SO4 and evapor- 
ated under reduced 
pressure. The 
residue is the non - 
ketonic fraction. 
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(f) Digitonin precipitation. 
For the separation of mixtures of steroids 
and the structural analysis of unknown steroids many 
applications have been made of the discovery by 
'7indaus (1909) that cholesterol will form a complex 
with digitonin that is insoluble in alcohol. Fern 
holz (1935) found that most 3Ç.- hydroxysteroids are 
precipitated by digitonin whilst most 3a-hydroxy- 
steroids and steroids without a hydroxyl group at 
position 3 are not. The exceptions to this rule 
have been summarized by Fieser and Fieser (1949) 
and the reaction has been reinvestigated by Haslam 
and Klyne (1953). These workers have shown that 
the formation of the complex is influenced by 
other functional groups in the steroid molecule. 
Following the extraction of the non- 
precipitated material (the 'a'- fraction) with ether; 
the complex was decomposed by warming with pyridine 
and the released material extracted by ether is the 
'p'- fraction. The procedure followed in this 
thesis is a modification of that described by 
Butt, Henly and !"orris (1948) and is shown in 
Fig. 4. It is known that some 3p- hydroxysteroids 




1. The material, containing no more than 0.5 mg. of 3p- 
hyd.roxysteroids, is transferred to a graduated glass - 
stoppered centrifuge tube and dried. Add 0.75 ml. of 
a 1¡ digitonin solution in 90% aqueous ethanol warmed 
at 37 °C. Fit a microcondenser to the tube and reflux 
gently for 30 min. The solvent is removed carefully' 
under reluced pressure. 
'2. 10 ml. of ether are added and the dry residue dis- 
persed with the aid of a thin glass rod. Centrifuge 
for 5 min. at 2000 r.p.m. Decant the supernatant 
into a 30 ml. separating funnel. Repeat this step 
with three 5 ml. portions of ether. 
SOLID RESIDUE " "SUPERNATANT AN 
WASHINGS 
1 
The residue is dissolved 
in 0.25 ml. of pyridine, 
warmed to 60 °C. for 
3 min., cooled and 5 
ml. of ether are added 
with stirring. 
Centrifuge, decant the 
supernatant into 
another 30 ml. funnel 
and repeat. The 
residue is further 
washed with 3 x 5 ml. 
of ether. 
1 
Wash F the combined ether 
supernatants three times 
with 5 ml. portions of 
dist. water. Dry with 
a pinch of anhydrous 
sodium sulphate, and 
evaporate. The residue 
is the 
a-Fracti;on 
. The combined ether supernatants are washed twice with 
5 ml. portions of 2N- sulphuric acid and three times 
with 5 ml. portions of dist. water. Dry with a 
pinch of anhydrous sodium sulphate and evaporate. 
The residue is the 
.L=Fraction 
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a- fraction by the ether added to the alcoholic 
medium. To overcome this, in the procedure 
described in Fig. 4, the alcohol was removed by 
evaporation in vacuo after the formation of the 
complex. 
(g) Crystallization of residues from urine extracts. 
Methanol has been the solvent most usually 
employed for the crystallization of compounds in 
this thesis. Crystallizations using methanol 
were performed at -20 °C. When the weight of 
material to be crystallized exceeded about 20 mg. 
or the volume of liquid used for crystallization 
exceeded 0.5 ml. the crystals were separated from 
the mother liquors by employing a 4Zuickfît semi - 
micro Willstätter filter assembly. The filter 
assembly and solvent for washing the crystals 
were cooled before use. For the removal of 
mother liquors of less than 0.5 ml. and washing 
the crystals and removal of the washing solvent 
the above filter assembly is of little use. A 
modification of the Skau centrifuge tube (Cheronis, 
1954) has been used and found to be satisfactory. 
The most satisfactory method for removing the 
mother liquors when these were less than 0.5 ml. 
in/ 
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in volume has involved the use of a piece of pipe- 
clay. The crystallization of the material took 
place in a small glass tube (5 x 1.3 cm.) at -20 °C. 
When crystallization was complete a piece of pipe -, 
clay (approximately 7 x 0.6 cm.), previously 
chilled to -20 °C., was placed in the small tube 
and the whole placed inside a stoppered boiling 
tube and left at -20 °C. The pipeclay absorbed 
the supernatant liquid leaving the crystals in the 
small tube. The time necessary for absorption of 
the mother liquors varied from 1. to 3 hr. The 
crystals were then dried in vacuo and weighed. 
The pieces of pipeclay were cleaned by 
refluxing with chloroform and methanol and then 
heating to redness. 
(h) Colour reactions. 
Blue tetrazolium reaction for a-ketolic steroids. 
The method of Chen, Wheeler and Tewell(1953) 
has been used. Improvements of this method have 
been described by Mader and Buck (1952) and Morris 
and Williams (1955). 
To the steroid contained in a glass -stoppered 
test tube 1 ml. of methanol, 1 ml. of a 1N solution 
of NaOH in 80¡ aqueous methanol and 1 ml. of a 1' 
methanolic solution of blue tetrazolium (BT) were 
added/ 
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added and the mixture allowed to stand in the dark 
in a water bath at 25± 2 °C. for 20 min. The 
reaction was stopped by the addition of 4 ml. of 
methanol -acid pyridine (3 parts of methanol to 1 
part of acid pyridine prepared by adding 20 ml. 
conc. hydrochloric acid to 100 ml. pyridine) and 
the solution stirred. The intensity of absorption 
of light of wavelength 520 mµ was measured using 
a Hilger Spekker photoelectric absorptiometer. 
Pettenkofer reaction. 
The method described by r'tInson, Jones, 
McCall and Gallagher (1948) has been used. The 
reaction is stated by the to be specific 
for steroids with unsaturation in ring B, or a 
group which can give rise to unsaturation in ring 
B, and a hydroxyl group or unsaturation in ring A. 
However the intensity of the colour produced in 
the reaction is also influenced by the presence of 
other functional groups in the molecule. 
To between 10 and 50 jig. of the steroid 
contained in a test tube 0.5 ml. of glacial acetic, 
acid was added followed by 2 ml. of furfural 
solution (0.56% v/v in 50% acetic acid) and 7.5 
ml. of 8M sulphuric acid. After stirring, the 
tube/ 
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tube was placed in a water -bath maintained at 
67± 0.2 °C. for 12 min. The tube was then removed, 
cooled in ice for 1 min. and the intensity of the 
colour produced read against a reagent blank at 
wavelength 660 mµ using the Hilger instrument. 
Since there was a day to day variation in the 
colour intensity produced by a given amount of 
steroid a set of standards (10 µg., 30 µg. and 
50 µg. of dehydroepiandrosterone) were included 
with each assay. 
Zimiaermann reaction. 
The modification of Callow, Callow and 
Emmens (1938) has been used. 
To the steroid dissolved in 0.2 ml. 
ethanol 0.2 ml. of 2 2, .m- dinitrobenzene in absolute 
alcohol end 0.2 ml. of 2.5 N- potassium hydroxide 
in absolute alcohol were added. After incubationl 
in the dark in a water bath maintained at 25 °C. 
for 60 min. 4 ml. of ethanol were added and the 
solution read against a reagent blank using 1 cm. 
cells at 10 mp intervals between the wavelengths 
410 mµ to 560 mµ . 
Spectra/ 
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Spectra of sulphuric acid solutions of steroids, 
The procedure described by Zaffaroni (1950) 
was followed. 
To between 70 4g. and 100 4g. of the 
steroid in a glass- stoppered test tube 4 ml. of 
concentrated sulphuric acid were added, the tube 
stoppered and placed in a water bath maintained at 
25 °C. for 2 hr. The resulting solution was then 
read against a sulphuric acid blank between the 
wavelengths 220 to 660 m4 using 1 cm. cells in a 
Unlearn S.P.500 spectrophotometer. 
(i) Acetylation of steroids. 
All acetylations have been performed at 
room temperature. Two procedures have been used. 
For micro amounts of steroids (less than 100 4g.) 
the method of Zaffaroni and Burton (1951) has 
been employed. To the steroid contained in a 
small glass -stoppered test tube 5 drops each of 
acetic anhydride and pyridine were added and the 
mixture left overnight. The solvents were 
removed in vacuo with the aid of methanol and the 
acetylated steroid dried in vacuo over cone. 
sulphuric acid. 
For the acetylation of larger amounts of 
steroids 
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steroids the substance was transferred to a 25 ml. 
glass stoppered flask and the required amount of 
pyridine and acetic anhydride added. After 
standing overnight the flask was filled with ice- 
cold water and the solution filtered. The 
acetylated steroid was well washed with water and 
dried in vacuo. 
(j) Melting point determinations. 
All melting points, unless stated otherwise 
were determined on a hot -stage microscope apparatu 
of the type described by Klyne and Rankeillor 
(1947) and are uncorrected. 
RF 
O- 










FIG.5. PAPERGRAMS OF EXTRACTS OF UNBOILED 
AND BOILED URINE SPRAYED WITH BLUE 
TETRAZOLIUM. SYSTEM. B5M. 
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3. quantitative estimation of BT reducing 
steroids in extracts of unboiled and boiled 
urine. 
Fig. 5 shows a typical chromatogram of 
extracts of unboiled and boiled urine sprayed 
with BT after development in system B5M. The 
positions of reference steroids are also shown. 
Cortisone, cortisol and a more polar compound 
(most probably 3a :17x:21- trihydroxy -53- pregnane- 
11:20- dione) were regularly present in extracts 
of unboiled urine. Three spots were also 
regularly present in extracts of boiled urine; 
compounds X and Y of a polarity similar to 11- 
deoxycortisol and a more polar compound. 
A rough indication of the amount of a 
substance present on a paper chromatogram can be 
obtained from the size of the spot and its 
intensity after the application of a suitable 
colour reaction. This method is only approximate 
and is especially inaccurate when BT is used since 
Chen, Wheeler and Tewell (1953) have shown that 
either one or two molecules of an a- ketolic 
steroid may react with BT. When completely 
reduced BT gives rise to a dark blue formazan 
but when only one half of the BT molecule is 
reduced/ 
-44- 
reduced the formazan produced is red. Thus when 
BT is used to estimate steroids quantitatively 
it must be present in large excess so that only 
the semi -reduced red formazan is formed. Cope and 
Hurlock (1954) found that the formazan produced 
from BT was readily soluble in acid pyridine and 
could be eluted from paper chromatograms with this 
solvent. The intensity of the colour at the wave- 
length of maximum absorption was then measured. 
Their recoveries ranged from 75% to 160% which is 
not very satisfactory. This method also proved 
unsatisfactory when tried by the author. Known 
amounts of cortisone were applied to a piece of 
chromatography paper, sprayed with BT, allowed to 
dry and equal areas of paper containing the spots 
cut out. A sprayed piece of paper of equal area 
was used as a blank. The pieces of paper were 
placed in a glass- stoppered tube with 5 ml. of 
acid- pyridine (1 vol. conc. hydrochloric acid to 
9 vols. pyridine) and left overnight. The next 
morning the solutions were filtered and the colour 
intensity measured at wavelength 520 mµ. As can 
be seen from Fig. 6 the curve relating optical 
density of the coloured solution to the amount of 
steroid used was not linear suggesting that when a 
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FIG.6. STANDARD CURVE OBTAINED USING THE 
METHOD OF COPE AND HURLOCK . 
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FIG.7. STANDARD CURVES OBTAINED USING THE 
METHOD DESCRIBED IN THIS THESIS . 
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not react with BT. 
It was thought that a better method of 
estimating the steroids after chromatography 
would be to elute the steroids before spraying 
and then to carry out the BT reaction of Chen, 
Wheeler and Tewell (1953). Varying amounts of 
cortisol were applied to chromatography paper and 
the positions of the spots located using an ultra- 
violet light. Equal areas of paper containing the 
spots of cortisol were cut out and placed in test 
tubes containing 5 ml. of methanol. After 
standing overnight the methanol was filtered into 
a clean tube and the first tubes rinsed with 
methanol which was also filtered. The BT reaction 
was carried out on the residues obtained after 
removal of the methanol in vacuo. Fig. 7 shows 
the results obtained. Although for any one set of 
determinations Beer's Law was followed over a wide 
range of concentration day to day variations occurred 
so that it was necessary to run a standard compound 
with each set of determinations. 
For the determination of compounds X and 
Y, cortisone and cortisol in normal male urine 
7/12 of a 24 hr. specimen were extracted, boiled 
and re- extracted as described in Section 2. One 
seventh/ 
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seventh of each residue, obtained after the 
partition procedure, from the tunboiledt and 
'boiled' extracts was used for the determination 
of formaldehydogenic substances (FSS) by the 
procedure described in Part 2. Aliquots each of 
3/7 of the residue were applied to chromatography 
paper accompanied by two 30 µg. portions of 
cortisol as shown in Fig. 8. After development 
in system B514í the solvent front was marked and 
the paper cut lengthways in half. One half was 
sprayed with BT and the positions of the spots 
which appeared were marked on the unsprayed half 
of the chromatogram. Equal areas of paper con- 
taining the compounds were cut out and treated as 
described above. A piece of paper of equal area 
containing no extract was cut out and used as a 
blank. The results are shown in Table 6. 
Table 6. / 
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Table 6. Quantitative determination of BT 
reducing compounds and FSS in extracts of 
unboiled and boiled urine. 
Urine 1 Urine 2 Urine 
Cortisone 10.5 38.5 30.5 
Cortisol µg. per 24 hr. 15.5 43.0 - 
Compound. Y 20.5 51.5 25.0 
Compound X 156.0 158.0 76.0 
'Unboiledt 
FSS. µg. sterol 
per 24 hr. 137 396 473 
'Boiledt 
FSS 316 327 253 
x A conversion factor of 11.4 (calculated for 
a C -21 steroid of molecular weight 340) has 
been employed to convert 4g. of formalde- 
hyde to 4g. of steroid. 
Fig. 8. Application of urine extracts to paper 
chromatograms. 
U Extract of unboiled urine 
B Extract of boiled urine 
S Reference steroid 
3 
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The opportunity arose of studying the effect 
of ACTH on the excretion of Compounds X and Y. 
The subjects were two males with coronary disease. 
The days on which ACTH was injected and the 
results are shown in Table 7. The increased 
excretion of Compounds X and Y in these experiments . 
supported the view that X and Y were steroidal and 
related to the adrenal cortex. 
It should be pointed out here that the above 
values for the excretion of X and Y do not represent 
the total amount of these compounds present in the 
urine. In all the above experiments the urine was 
boiled for only half an hour. As shown in 
Section 5 this would not be long enough to 
hydrolyse completely the conjugates of X and Y. 
Work performed at a much later date also shows 
that the values recorded above are incorrect but 
since all the estimations were performed under 
similar conditions the figures do have some 
comparative value. 
Table 7. / 
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Table 7. Quantitative determination of DT 
reducing compounds and FSS in extracts 
of unboiled and boiled urine from males 
injected with ACTH. 
Male 1 
Day 1 Day 2 Day 3 
Cortisol 52 640 66 
Cortisone 4g. per 24 hr. 26 137 60 
Compound Y 56 155 78 




per 24 hr. 
570 1228 338 
'Boiled 275 1424 506 
FSS' 
100 i.u. of ACTH injected intramuscularly 
on the morning of Day 2. 
Male 2 
Day 1 Day 2 
Cortisol 32 600 
Cortisone Ig. 16 80 
Compound 
24r 25 88 Y 
hr. 
Compound 100 400 
X 
'Unboiled µg. 
FSS' ster- 378 1183 
oid 
'Boiled 
per 400 252 
FSS' 
hr. 
Day 3 Day 4 Day 7 
672 1900 13 
16 160 33 
144 132 26 
336 320 70 
550 1512 125 
288 1100 80 
100 i.u. of ACTH injected intramuscularly on 
the morning of Day 2, Day 3 and Day 4. 
x A conversion factor of 11.4 (calculated for a 
C -21 steroid of molecular weight 340) has 
been employed to convert 4g. of formaldehyde 
to 4g. of steroid. 
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Although no recovery experiments have been 
performed it is thought that the method described 
above is fairly accurate. The optical density of 
the solution resulting from the reaction of BT and 
the cortisol standard used in the above experiments 
agrees well with the optical density of the solution 
obtained by the reaction of BT with cortisol which 
has not been chromatographed and eluted. Zaffaroni 
(1953) has shown that elution of steroids from 
paper by methanol is quantitative. The extraction 
of urine with 2 vols. of CHC13 should remove all 
steroids as polar as cortisone or cortisol 
quantitatively; it may be necessary however to 
use ethyl acetate to extract the very polar highly 
oxygenated steroids. It has been shown by Dr A. 
Colás that no losses occur during the partition 
procedure. In addition the values found for the 
excretion of cortisol and cortisone agree well with 
the values reported by Burton, Zaffaroni and 
Ieutmann (1951), de Courcy, Bush, Gray and Lunnon 
(1953) and Cope and Hurlock (1954). 
4. The stability of X and Y to acid. 
The stability of the compounds to both hot 
and cold acid was determined. A sample of X 
obtained/ 
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obtained by paper chromatography of extracts of 
boiled urine was dissolved in 350 ml. of 1% 
methanol in water and the solution divided into 
seven equal parts. One part was unacidified, 
a - second was boiled for 20 min. with 15 vols. 
conc. hydrochloric acid and the remainder acidified 
to pH 1 with sulphuric acid and allowed to stand 
at room temperature for 0, 2, 4, 7 and 24 hr. 
After the treatment described above each solution 
was extracted and prepared for chromatography. The 
results showed that after hot acid treatment very 
little BT reacting material remained and part of 
the material remaining ran with the solvent front 
on chromatography. Standing for 2 hr. or more 
at pH 1 transformed X into a compound with the 
same polarity as Y and this tranformation product, 
called Xa, was stable to cold acid. 
A similar experiment performed with Y 
showed that it too was destroyed by hot acid but 
was stable to cold acid. 
The destruction of X by hot acid was not 
surprising in view of the fact that X reduced BT 
and therefore was assumed to have an a ketol group. 
Since the transformation caused by cold acid did 
not result in a decreased power to reduce BT some 
part/ 
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part of the molecule of X other than the a-ketol 
group must be involved. The effect of acid could 
be explained if it was assumed that X was a 
steroid with the 3:5-cyclo-6p-hydroxy structure. 
(Other evidence supported this assumption). It 
was shown by Dingemanse, Huis in't Veld and 
Hartogh-Katz (1948a,b) that i- androstanolone 
(3:5- cycloandrostan- 6ß -o1 -17 -one) could be 
isolated from urine when the urinary conjugates 
were hydrolysed by boiling at neutral pH and the 
steroids liberated continuously extracted with 
benzene. Treatment with 5% hydrochloric acid at 
room temperature produced 80% of 3ß- chloro - 
androst- 5 -en -17 -one and 20% of dehydroepi- 
androsterone (Dingemanse, Huis in't Veld and 
Hartogh-Katz, 1948b). The chloro- compound is 
less polar than the cyclo- compound so that if X 
was a cyclo- steroid the cold acid transformation 
product could not be the chloro -derivative but 
would have to be the steroid with the 3ß hydroxy- 
5 -ene structure. As noted above i- androstanolone 
produces less than 20% of dehydroeptiandrosterone 
under these conditions. 
These transformations are shown in Fig. 9 
and are taken from the paper by Teich, Rogers, 
Lieberman/ 
3 J.). KO SO 
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Lieberman, Engel and Davis (1953). These authors 
have suggested that the steroid sulphate which 
occurs in urine is dissociated by heat with the 
formation of a carbonium ion which has a resonating 
structure. The product or mixture of products 
obtained from the hydrolysis depends upon the 
conditions of hydrolysis. 
In the above experiments on the lability of 
X to acid at room temperature sulphuric acid had 
been used. The suggestion that X may be a cyclo- 
steroid was strengthened by its behaviour during 
the Girard separation. In the work of Dingemanse 
et al. quoted above, during the Girard separation 
80rí of i- androstanolone was transformed to the 
chloro- derivative and 20¡% to dehydroepiandrosterone. 
When the Girard separation was performed with 
Compound X 30c/-50,2, was transformed to Xa and the 
remainder was transformed to a BT reducing 
compound which runs with the solvent front during 
paper chromatography. This non -polar derivative 
could well be the chloro- compound. Because of the 
above transformations sulphuric acid has been used 
to hydrolyse the Girard hydrazones in the present 
work. Using sulphuric acid the product appears 
to/ 
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to be entirely Xa. Wolff and'7allis (1952) have 
suggested the scheme shown in Fig. 10 for the 
conversion of the cyclo- steroid by acid. The 
hydroxyl group of the cyclo- steroid (I) is 
protonated with the formation of II. The hydroxyl 
group is thus removed with the formation of the 
carbonium ion III. The limiting structure V is 
favoured is an acid medium and this reacts with 
water to form the hydroxy- steroid VI. When 
hydrochloric acid is used V must react more 
quickly with chloride ions than with hydroxyl ones 
producing predominantly the chloro- steroid. It 
that 
has been shownbethers of the cyclo-steroid react 
with halogen acids in acetic acid solution at room 
temperature forming the halide of the normal 
steroid (Beynon, Heilbron and Spring, 1936) but 
with sulphuric acid in acetic acid the acetate of 
the normal steroid was formed (Wagner, Wolff and 
Wallis, 1952). 
As reported above chromatograms of boiled 
urine showed a BT reducing spot Y which is slightly 
more polar than X and the relative amounts of X 
and Y present sere approximately the same for 
different urines. Dingemanse (1952) found 
that/ 
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that i- androstanolone obtained by h;ydrolysis of 
the urinary conjugate was always accompanied by 
about 10, of dehydroepiandrosterone depending 
upon the pH. Thus it could be that Y and Xa 
are identical but there is no conclusive evidence 
for this assumption. 
5. Liberation of forrnaldehydogenic substances 
(FSS) by boiling. 
It was known that when pre -extracted 
urine was boiled for periods of time varying 
from 10 to 40 minutes the amounts of FSS extract- 
able varied only slightly. It was possible 
however that reboiling the urine after extraction 
would liberate further amounts of FSS. To test 
this possibility a 24 hr. sample of urine was 
divided into two equal parts A and B after being 
extracted with chloroform and treated as shown 
below : - 
A. B. 
Divided into 4 equal 
parts 
Al boiled ¡ hr. 
A2 boiled hr. 
A3 boiled 12 hr. 
A4/ 
Bl boiled ¡ hr. ex- 
tracted with CHC13 
B2 extracted (B1) uriné 
boiled ihr., ex- 
tracted with CHC13 
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-56- 
A4 boiled 2 hr. 
Each part extracted 
with CHC13 for 
determination of 
FSS 
B4 urine from B3 boiled 
¡hr., extracted with 
CHC13 
4 of each CHC13 extract 
used for determination 
of FSS 
The results are shown in Fig. li, frequent 
chloroform extraction appeared to favour the 
release of larger amounts of FSS. A similar 
result was obtained when the experiment was 
repeated in a slightly different manner. One 
half of a sample of urine was boiled for four 
periods of 2 hr. and extracted at the end of each 
period of boiling (extracts Al, A2, A3, A4). The 
other half of the sample waz boiled for ¡ hr., 
extracted and this extracted urine allowed to 
stand at room temperature and extracted at half 
hourly intervals (Bl, B2, B3, 
for FSS obtained are shown in 
B4). The values 
Fig. 12. Thus 
boiling for a short period of time does not cause 
complete hydrolysis of the conjugated FSS. 
Paper chromatography showed that reboiling 
of urine also liberated more of Compounds X and Y. 
When a sample of urine was boiled for three 
periods of one hour and extracted at the end of 
each period, even the third extract contained 
large/ 
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large amounts of X and Y. Some spots which 
fluoresced in ultraviolet light but did not reduce 
BT were also present. Some of these appeared in 
the second and third extracts but not in the first. 
When urine was refluxed for three periods of 1 hr. 
with toluene, fresh toluene being used for each 
period, the third toluene extract still contained 
Compounds X and Y. 
As already noted Dingemanse et al. have 
isolated i- androstanolone by continuous extraction 
of hot neutral urine with benzene. Using 1/3 vol. 
of benzene two or three periods of heating for five 
hours were needed for complete hydrolysis and 
extraction of the steroid. Jensen and Totterman 
(1952) have described a two stage hydrolytic 
procedure for 17- ketosteroid conjugates in urine. 
The first stage consisted of heating the urine at 
100 °C. without continuous extraction. It was sho i 
that after heating for 6 hr. the yield of the 
dehydroepiandrosterone fraction remained practicall 
constant and that no further amounts of dehydroepi- 
androsterone were released by subsequent acid 
hydrolysis. Changes in pH of the urine from 3 to 
11 did not affect the amount of dehydroepiandrosterone 
detected in the first stage. Talbot, Ryan 
and/ 
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and Wolfe (1543) and Bitman and Cohen (1951) have 
also described methods of hydrolysing urinary 
17-ketosteroid conjugates by heating at pH 5.8 
and 4.7 respectively. Talbot et al. using an 
aqueous solution of sodium dehydroepiandrosterone 
sulphate showed that hydrolysis was complete after 
four hours' heating at 100 °C. and the recovery of 
17-ketosteroid was satisfactory at any pH between 
4 and 7. Bitman and Cohen found that hydrolysis 
was only 85¡ complete in four hours and that twelve 
hours were needed for complete hydrolysis. The pH 
at which the urine was heated had little effect 
until a pH of 3 or less was reached; the quantity 
of 17- ketosteroids liberated between pH 4 -6 was 
approximately constant and accounted for about 
25% of the 17- ketosteroids liberated by acid 
hydrolysis. Using synthetic steroid sulphates 
only those containing the sulphate group at the 
3e- position and unsaturated at position 5 were 
hydrolysed. About one half of the 17- ketosteroids 
in a urine hydrolysate were precipitated by 
digitonin and dehydroepiandrosterone was isolated 
from this fraction. 3- Chloro -androst- 5 -en -17 -one 




Thus the values quoted in Section 3 for the 
excretion of Compounds X and Y must be minimal 
ones. It would appear that a continuous extraction 
of hot urine by benzene for at least 5 hr. would 
be necessary for complete kjdrolysis and extraction 
of X and Y. 
. Acetylation of X. 
Zaffaroni and Burton (1951) have shown that 
it is possible to decide whether a compound has 
one or more than one hydroxyl group that can be 
acetylated by the difference in R, value of the 
free and acetylated compound. If a steroid has 
only one hydroxyl group that can be acetylated 
the Rr value of the acetylated compound is only 
slightly greater than that of the free compound. 
If more than one hydroxyl group can be acetylated 
the resulting acetate is usually a non -polar 
compound and runs near the solvent front. 
About 100 µg. of X was obtained by eluting 
papergrams of boiled urine extracts. 15 µg. were 
again chromatographed on paper to check its purity 
and the remainder acetylated. The R 
F 
values 
obtained for X, il- deoxycortisol and 11- dehydro- 
corticosterone and their acetates in various 
chromatographic / 
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chromatographic systems are shown in Table 8. 
From these values it is clear that X must contain 
at least two hydroxyl groups. 
Table 8. R. values for compound X, reference 








X acetate 1.0 0.86 
11- deoxycortisol 0.32 
u acetate 0.70 
11-dehydrocorticosterone 0.49 
n acetate 0.75 0.04 
7. Digitonin precipitation of X and Xa. 
One half of a sample of X (about 200 P-g.) 
was treated with acid to form Xa. Both X and Xa 
were then subjected to the digitonide formation 
procedure. Xa appeared in the Ç- fraction while X 
appeared in the a- fraction. 
Thus bearing in mind the limitations of the 
method described in Section 2 it was probable that 
Xa contained a 3p- hydroxyl group which was absent 
in X. X and Xa behaved in this test in a 
sir. ila.r/ 
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similar manner to i- androstanolone and dehydro- 
epiandrosterone. 
The probability that Xa contained a 3p- 
hydroxyl group was strengthened by comparing the 
reaction of Xa and deh.ydroepiandrosterone in the 
Pettenkofer reaction; approximately equal amounts 
of the two compounds produced the sane intensity 
of colour. 
. Summary. 
It has been shown that chloroform extracts 
of boiled urine contain substances which reduce 
3T and which do not occur in chloroform extracts 
of unboiled urine. Compounds X and Y have been 
found in all urines examined and are the BT 
reducing substances present in largest amounts. 
A very polar compound was also usually present and 
other substances in small amounts. 
After the administration of ACTH not only was the 
excretion of X and Y increased but many other BT 
reducing substances were detected on chromatograms. 
Since neither X nor Y absorbed ultraviolet light 
of wavelength 254 mµ or gave a positive sodium 
hydroxide fluorescence reaction (Bush, 1952) they 
were unlikely to contain an ap unsaturated ketone 
group. If X and Y were steroids the positive 3T 
reaction/ 
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reaction suggested they were C -21 steroids 
with an a ketol side -chain and this suggestion 
appeared likely since extracts containing X and Y 
liberated formaldehyde on periodate oxidation. 
From their chromatographic behaviour it was 
likely that they contained four oxygen atoms as 
do corticosterone, 11- dehydrocorticosterone and 
11- deoxycortisol which have similar RF values to 
X and Y. One of these oxygen atoms must be 
present as a ketone group for X and Y are found 
in the ketonic fraction on performing the Girard 
separation. Acetylation suggested that at least ! 
two hydroxyl groups were present, one presumably 
at 021 and from the digitonin precipitation and 
Pettenkofer reaction of Xa the other was present 
at position 3. The mode of hydrolysis suggested 
that X and Y arose from a conjugate esterified at 
position 3 and with a double bond at position 5. 
If so the transformation by acid was explained as 
conversion of the cyclo- steroid produced by the 
hydrolysis to the normal compound. No 17-keto- 
steroid was detected after sodium bismuthate 
oxidation suggesting that a hydroxyl group was 
not present at position 17. 
By working up about 400 litres of normal 
male/ 
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male urine Col?.s (1955) isolated two crystalline 
compounds. The first, Kl, was shown to be 3p- 
chloro- androst- 5 -en -17 -one and 4.5 mg. of the 
second, designated K2, were obtained. The method 
of isolation consisted of a Girard separation of 
the residue from the partition procedure and 
chromatography of the ketonic fraction on a Celite -r 
magnesium silicate column. Those fractions shown 
by paper chromatography to contain Xa were combined 
and rechromatographed on a small Celite- magnesium 
silicate column. K2 had a melting point of 177 - 
181 °C., was not formaldehydogenic, gave a negative 
Zimmermann reaction, and under the conditions of 
the reaction then employed did not appear to reduce 
3T. With concentrated sulphuric acid an intense 
purple colour with a green fluorescence was 
produced and the absorption spectrum showed 
maxima at 271, 378, 400 and 560 mp , minima at 
250, 315, 390 and 458 m4 and an inflection at 
496 mµ . Little could be deduced from the 
spectrum except that K2 probably contained a 5-en- 
3p -ol group. A. quantitative carbon and hydrogen 
analysis left the empirical formula in doubt. The 
infrared spectrum suggested that a progesterone - 
like side -chain or ketone groups in positions 3 or 
17 were absent. A strong band at 1740 cm. -1 
suggested/ 
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suggested a cyclo -pentanone and since K2 gave a 
negative Zimmermann reaction it was assumed that 
the ketone group was present at position 16. The 
mother liquors from which K2 had been c-ystallized 
and which were expected to contain X did not 
appear to reduce BT. 
The residue from a second pool of urine 
was fractionated in a slightly different manner. 
The residue was first chromatographed on a 
magnesium silicate -Celite column and those 
fractions shown to contain Compounds X and Y were 
combined and subjected to a Girard separation. 
The ketonic fraction was then chromatographed on a 
small column of magnesium silicate -Celite and the 
fractions containing Xa combined. Three 
crystallizations from methanol gave 7.9 mg. of 
K2. K2 was shown to give a positive Pettenkofer 
reaction and to be precipitated by digitonin. 
Again it did not appear to reduce BT but the 
mother liquors from which K2 had been crystallized 
did. The analysis of K2 was again not helpful. 
The nearest possible empirical formula to fit the 
analysis was C21H3004 but the agreement was not 
very good. 
Thus although some of the properties of X 
and Xa were known, their isolation was apparently 
not/ 
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not achieved. K2 was assume__ to be a steroid 
with a 5- en -3p -ol grouping and with a ketone group 
at position 16. The number of carbon atoms present 
,.n its molecule was unknown. 
Fractionation of the first pool of urine. 
The residue obtained from 165 litres of 
urine weighed 1.06 g. After chromatography on 
magnesium silicate- Celite the X fraction weighed 
0.756 g. 
separation 
This was subjected to a Girard 
and the hydrazones formed hydrolysed 
with hydrochloric acid. The weights of the 
fractions were:- 
Non- ketonic fraction 308.7 mg. 
Ketonic fraction 222.0 mg. 
The ketonic fraction was rechrorcatographed on 
magnesium silicate- Celite. Paper chromatography 
of the fractions from the column showed that 
during the Girard separation about half of the 
Compound X had been converted to Xa and the 
remainder to a non -polar compound running with the 
solvent front, presumably the 3- chloro- derivative 
of X. The fractions containing these two 
co°lpounds were combined since complete separation 
had not been obtained and rechromatographed on a 
small column of magnesium silicate -Colite. The 
two/ 
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two co:..pounds were completely separated and the 
weight of the combined Xa fractions was 67.5 mg. 
whilst that of the non -polar fractions was 87.1 mg. 
(a) Examination of the non -polar material. 
The isolation of K3. 
The residue containing the non -polar material 
was dissolved in 0.5 ml. of methanol and left at 
-20 °C. to crystallize. The crystals which formed 
were removed by filtration and designated K3. 
After dissolving in methanol, filtering and re- 
crystallizing twice more the white crystals weighed 
11.7 mg. The melting point was recorded:- 
154 ° -160° Softening of the crystals occurring 
at the edges. 
167° Slowly beginning to melt. 
170° -elting becoming more rapid. 
176° iIelt complete. 
A sample was dried to constant weight for 
analysis and gave the following f iEures:- 
C, 72.58 H, 8.26;' Cl, 11.5;;; 
There was no residue after combustion. The result 
of the chlorine analysis may be 0.45 high since 
the analysis of known compounds gave values for 
chlorine in error by this amount. 
Thus possible formulae for K3 are: 
C21H2 9C1 C, 72.3; H, 8.37;', Cl, 
C1 5H2702C1 C, 70.7% H, 8.37% Cl, 11.0;_ 
Due/ 
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Due to the small amount of material 
available K3 was not investigated further. 
Addi tional comments regarding the structure of 
K3 appear in later sections of this thesis. 
When 1/150 of the residue obtained from 
the mother liquors of the first crystallization 
of K3 was chromatographed in system B2 a large BT 
reducing zone, representing about 50 µg. (visual 
estimation), was seen at the solvent front. 
The isolation of K4. 
Since the isolation of K3 appeared not to 
have resulted in the loss of any of the BT 
reducing material which had been presumed to be 
the chloro- derivative of Xa, an attempt was made 
to isolate this compound from the mother liquors 
of the first crystallization of K3. One half of 
the residue from the mother liquors (weight 42.2 
mg.) was chromatographed on a 15 x 1 cm. column 
of Celite using methanol:water - 8:2 as the 
stationary phase. The mobile phase was petroleum 
ether (boiling range 80- 100 °C.). Eleven fractions 
of 5 ml. each were collected and 1/50 of each 
fraction chromatographed on paper in system A. 
The only BT reducing spots detected were in 
fractions 2, 3 and 4 and all had an RF value of 
0.70. The residue obtained from combining 
the se/ 
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these fractions weighed 13.1 mg. Two crstalliz- 
ations from methanol gave 2.7 mg. of a slightly 
ellow amorphous residue with a few white plates. 
The melting point of the white crystals was 157- 
176°0. When 50 µg. of the compound were chror,ato- 
graphed in system A a faint BT reducing spot, 
representing about 2 -5 leg. of an aketol, of R-51 
0.70 was seen. Thus it was assumed that K4 was 
not the chloro- derivative of Xa but may have 
contained 5 -10 ¡: of this substance as a contaminant. 
It seems possible that K4 is identical with K3. 
The isolation of K5. 
Evaporation of the solvents from 
fractions 8 and 9 of the partition coluin described 
above left a residue of crystalline material. 
The two fractions were combined (weight 5.0 mg.) 
and crystallized from 0.05 ml. of methanol to 
give 4.6 mg. of white needles. The melting point 
was recorded: - 
137° Beginning to melt. 
139° Resolidifies. 
144° Beginning to melt again. 
147° r.Ielt complete. 
The/ 
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The melting point behaviour was similar to 
that of dehydroepiandrosterone; Butenandt, 
Dannenbaum, Hanisch and Kudszus (1935) record the 
melting point as 137 -138 °, 148 °; Hirschmann and 
Hirschmann(1947) 139.5, 147.5 - 149 °C. and Lieberman, 
Dobriner, Hill, Fieser and Rhoads (1948) give 
137 -138, 145 - 146 °C. There was no depression of 
the melting point when authentic dehydroepi- 
androsterone was mixed with K5. It was thus 
concluded that K5 was dehydroepiandrosterone. 
(b) Examination of the Xa fraction. 
The isolation of K6. 
Cols had isolated only small amounts of K2. 
This was in part due to the number of crystallizations 
that were necessary to produce a pure product. It 
seemed possible that the number of crystallizations, 
could be reduced if a purer product was obtained 
from column chromatography. A partition column 
seemed most suitable for purifying the Xa fraction. 
Cox (1952a) had found that the partition 
coefficient for 11- deoxycortisol in the solvent 
system methanol, water, benzene, 8:2:10 to be 
5.3. Since Xa was slightly more polar than 
11- deoxycortisol this system should be suitable 
fort' 
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for the purification of Xa. The residue (weight 
67.5 mg.) of the Xa fraction was accordingly 
chromatographed on a 32 x 2 cm. column of Celite 
using the above solvent system. Fractions 9 and 
10 of the eluate after removal of the solvent were 
crystalline. Those fractions (numbers 9 -15) 
shown by paper chromatography to contain Xa were 
combined. The weight of the residue obtained 
was 30 mg. This was crystallized three times 
from methanol and once from benzene producing 
7.5 mg. of crystals which had the same form as K2. 
The melting point was determined: - 
90-95° Went opaque 
172° Beginning to melt slowly 
175° Melting becoming more rapid 
181° Melt complete 
This was similar to the melting point of 
K2 and the melting point of a mixture of K2 and 
K6 showed no change from that recorded for K6. 
Thus it was concluded that K6 and K2 were 
identical. This was confirmed by the spectra of 
the sulphuric acid chromogens. Both compounds 
when dissolved in conc. sulphuric acid produced a 
pink solution with a green fluorescence which had 
the/ 
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the following features:- 
K2 K6 
Maxima 271,378,400,560 270,380,490 
Minima 250,315,390,458 250,300,460 
Inflections 496 400,490 
An aliquot of the mother liquors from the 
crystallization of K6 and 20 µg. of crystalline 
K6 were chromatographed on paper. The crystalline 
K6 showed a BT reducing spot of about 3 4g. of 
the polarity of Xa while the mother liquors_ 
showed a large zone of BT reducing material 
(about 50 4g.) of the same polarity. Thus it 
seemed to appear that K6 might still contain Xa 
as an impurity and this would account for the 
wide range of temperature over which K6 melted. 
Chromatography of the acetate of Xa. 
Katzenellenbogen, Dobriner and Kritchevsky 
(1954) have described a system suitable for the 
chromatography of non -polar compounds on a 
column. The supporting material is silica gel 
with ethanol (4 ml. per 10 g. of silica gel) as 
stationary phase and petroleum ether, methylene 




The residue (wt. 4.8 mg.) from the mother 
liquors of the K6 crystallization was acetylated 
at room temperature overnight. On chromato- 
graphy on silica gel, BT reacting material was 
eluted between 10 and 22 ml. (Al) and by washing 
the column with ethanol (A2). Total amount of Al 
obtained was 2 mg. and the amount of A2 was 
smaller than this. Both fractions were twice 
recrystallized from methanol but only waxy 
residues were obtained. When the BT reaction 
was performed on paper with 1 /10 of each residue 
Al gave a strong reaction and A2 a weak one. 
Due to the small amounts of material 
available it is not possible to make any conclusion 
regarding the nature of Al and A2. It is possible 
that Al was the diacetate of Xa whilst A2 could 
have been the monoacetate. 
10. Fractionation of the second and third pools. of urine. 
From the second pool consisting of 187 
litres of urine 50 mg. of crude material were 
obtained after chromatography. Three crystalliz- 
ations from benzene gave 28.8 mg. of crystalline 
K2 shown by the melting point to be slightly less 
pure than the previous batch and the residue from 
the/ 
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the combined mother liquors weighed 22.4 mg. 
Two 25 4g. aliquots of each fraction were 
chromatographed on paper in system B2 with 11- 
deoxycortisol as a reference compound. One half 
of the paper was sprayed with BT and the other 
half with the dinitrophenylhydrazine reagent 
described by Kochakian and Stidworthy (1952). 
It was considered that the paper sprayed with BT 
would reveal only Compound Xa in the mother 
liquor residue and the 11- deoxycortisol standard 
since K2 at that time was thought not to be BT 
reducing. K2 being ketonic should react with 
dinitrophenylhydrazine so that the mother liquor 
residue should show two spots Xa and K2 when 
sprayed with this reagent. Spraying with BT 
showed that about 7 4g. of Xa were present in 
the crystalline K2 and about 4 µg. in the mother 
liquor residue. On spraying with the dinitro- 
phenylhydrazine 11- deoxycortisol gave an orange 
spot characteristic of an aß- unsaturated ketone 
and only two yellow spots, characteristic of an 
isolated ketone group, were observed and these 
corresponded with the BT reducing spots. 
Thus the expected result was not obtained. 
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FIG.13. ABSORPTION SPECTRUM OF K2 IN CONC. H2504 
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Xa and K2 had exactly identical chromatographic 
properties or that the ketone group in K2 was 
for some reason unreactive to dinitrophenyl- 
hydrazine. 
From the third pool of urine (201 litres) 
16 mg. of pure K2 were obtained and the mother 
liquor residue weighed 64.8 mg. The K2 from the 
2nd and 3rd pools was combined with that remaining 
from the 1st pool and with 7.9 mg. donated by Dr 
Colas. The total weight of K2 so obtained was 
38.6 mg. This was crystallized once from 50% 
aqueous methanol and once from benzene to give 
27.2 mg. of pure K2 (melting point 176-180°C.) 
and a residue of 8.1 mg. from the mother liquors. 
Properties of K2. 
The spectrum of the sulphuric acid 
chromogen of K2 is recorded in Fig. 13; it did 
not differ from that recorded by Colas for his 
sample of K2. 
When 56 4g. of K2 were chromatographed in 
system B2 with 20 4g. of 11- deoxycortisol as 
reference steroid spraying with BT showed a blue 
spot corresponding to approximately 5 4g. of an 
a -ketol and with an RF value similar to that of 
Xa. Thus it was assumed that K2 contained about 
10¡ / 
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ic% of Xa in spite of its extensive purification. 
The oxidation of 112 µg. of K2 with periodic acid 
did not produce any acetaldehyde (Cox, 1952b) 
but did produce 1.4 µg. of formaldehyde. Assuming 
a conversion factor of 11.4 (calculated for a 
021 ketolic steroid of molecular weight 340) this 
amount of formaldehyde corresponded to 16 µg. of 
steroid confirming the result obtained with BT. 
However the formaldehyde detected in this experi- 
ment must be ascribed to experimental error for 
when this determination was repeated on another 
sample of K2 no formaldehyde was detected. 
The Zimmermann reaction performed with 
112 µg. of K2 did not show a peak of absorption 
between 400 and 530 mµ. confirming the result 
obtained by Colas. 
The analysis of K2 (dried to constant 
weight) gave the following: - 
Carbon 75.06% 
Hydrogen 8.86% 
Oxygen 16.08% (by difference) 
Thus possible formulae for K2 could be:- 
C19 H26 03 Carbon 75.46% Hydrogen 8.67¡ 
C19 H28 03 " 74.96% 9.27% 
The optical rotation of K2 was measured 
using a micro- tube:- 
Ca] D5 = +11.8 (2.875 
mg. K2 in 0.5 ml. EtOH 
c = 0.575) 
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13.67 mg. of K2 were acetylated with acetic 
anhydride and pyridine overnight at room temper- 
ature. The isolated acetate weighed 17.6 mg. 
Thus the increase in weight on acetylation was 
3.93 mg. and these values can be used to determine 
the number of acetylable groups in the molecule 
of K2. From the above 
cri. Acetate = 3.93 x 100 = 28.7 
/0 Steroid 13.67 
Assuming K2 to have a molecular weight of 304 
(calculated for Cis H28 03) then for a mono -acetate:- 
Acetate - 42 x 100 = 13.9 
l° Steroid 304 
For a di- acetate:- 
c5, Acetate = 84 x 100 = 27.8 
/0 Steroid 304 
Thus K2 formada diacetate and the result . 
obtained earlier by the increase in RF on 
acetylation was confirmed. 
When 100 µg. of K2 diacetate were applied to 
paper and sprayed with BT there was a positive 
reaction corresponding to about 3 4g. of 11- 
deoxycortisol. An equal amount of the residue 
from the mother liquors of the K2 diacetate 
crystallization treated similarly gave a positive 




The melting point of the diacetate after 
two crystallizations from methanol was 167 -171 °C. 
The analysis of a sample of the diacetate (no 




Oxygen 20.23% by difference 
For the diacetate of 019112503:- 
Carbon 71.5% Hydrogen 7.77% 
For the diacetate of 019112803:- 
Carbon 71.1% Hydrogen 8.25% 
Determination of the optical rotation of the 
diacetate gave the value ra3D2 = +22.9 
(3.010 mg. in 0.5 ml. EtOH c = 0.602) 
From the above results, especially the 
optical rotations, it was possible to derive new 
facts about the structure of K2. It seemed 
certain from the results of the analyses that 
if K2 is a steroid it has 19 carbon atoms and the 
probable formula is C19 H28 03. Assuming K2 to 
have a 5 -en -313 -o1 grouping and a ketone group, 
which infrared evidence suggested was in ring D, 
then another hydroxyl group has to be accounted 
for. Possible positions of hydroxyl groups, 
based/ 
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based on the C19 steroids isolated from urine, 
are 3, 6, 11f, 16 and 17 ( cf. General Intro- 
duction). Of these position 3 is excluded since 
it already contains one hydroxyl group and if K2 
has a 5- en- 3P-ol group, position 6 can also be 
excluded. The 11(3 position is possible but 
improbable; this position is a hindered one and 
acetylation of an 11P- hydroxyl group has only 
recently been accomplished and needs a strong 
acid catalyst (Oliveto, Gerold, 'Veber,4orgensen, 
Rausser and Herschberg, 1953). However Steiger 
and Reichstein (1937) found that 3ß:1lß -dihydroxy 
5a- androstan --17 -one formed a diacetate on heating 
with acetic anhydride and pyridine and Kemp, 
Kappas, Salamon, Herling and Gallagher (1954) 
have shown that the same compound can be partially 
acetylated at the 11- hydroxyl group at room 
temperature. Thus the most likely position for 
the remaining hydroxyl group is at C16, if this 
is not occupied by a ketone group, or at C17. 
From the BT reaction and the liberation of 
formaldehyde it would appear at first sight that 
K2 must be contaminated to the extent of 5 -10% 
even though the sample of K2 used had been 
crystallized six times. Apparently also acetylation 
and crystallization of the acetate was not effective 
-79- 
in removing the impurity. 
The contribution of substituents in the 
steroid molecule to the molecular rotation, M D , 
for that compound has recently been well reviewed by 
Klyne (1955). The contribution of the 5- en -3ß -ol 
group is about -245 and that of a 16 -oxo group, 
which has the strongest influence of any sub - 
stituent, about -450. Thus if K2 contained both 
of these groups or only a 16 -oxo group it should 
be strongly laevo rotatory. The fact that K2 is 
slightly dextro rotatory eliminates completely the 
16 -oxo group. To counteract the laevo rotatory 
contribution of the 5- en -3ß -ol group the remaining 
substituents must exert a dextro rotatory 
influence. Possible positions for such ketone 
groups are 7 in the 5a series ( +220), 11 ( +80) and, 
17 ( +250). Fòsition 7 is eliminated for with 
unsaturation at position 5 such a steroid would be 
an aß- unsaturated ketone and therefore absorb in 
ultraviolet light which K2 does not. The 11 
position can also be excluded since it has been 
shown that a ketone group in this position does 
not react with Girard's reagent (Mason, 1948). 
Position 17 is only possible if there is some 
neighbouring substituent to account for the 
negative Zimmermann reaction. If a ketone group 
is/ 
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is present at position 17 then the position 
cannot also have a hydroxyl group and the most 
probable position for the hydroxyl group becomes 
position 16. The rotation contribution for a 
16a- hydroxyl group varies from -30 to -160 whilst 
that of a 163 one is +20. 
The values quoted above for the rotation 
contributions of the various groups assume that 
no vicinal action occurs (Barton and Cox, 1948). 
Considering the structure first assumed for K2, 
3(3:170- dihydroxy- androst- 5 -en -16 -one, it is rather 
unlikely that vicinal action would be strong 
enough to convert what was anticipated to be a 
laevo rotatory compound into a dextro rotatory 
one. This structure can be completely eliminated 
since the compound has been synthesized by a 
number of workers and its properties (m.p. 202 - 
205;1 -195; Adams, Patel, Petrow and Stuart- 
Webb, 1956) do not coincide with those of K2. 
Thus a possible structure for K2 which accords 
with the experimental evidence is 3:16 -dihydroxy- 
androst- 5 -en -17 -one, assuming that none of the 
substituents occurs at an unusual position in the 
molecule. Table 9 compares the molecular rotation 
contribution of the 16- hydroxyl and 16- acetoxyl 
group in K2, assuming it to have the above 
structure/ 
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structure, with the value for these groups in 
other 17- ketosteroids. The results are not in 
disagreement with the postulated structure for 
K2. Only one value for a l6ß -acetoxy group and 
none for a l6ß -hydroxyl group can be calculated. 
On rotational evidence it is not possible to 
decide whether the hydroxyl group at position 16 
is in the a or 3 configuration. Cooley, Ellis, 
Hartley and Petrov (1955) have synthesized the 
diacetates of the two possible compounds and the 
physical properties of these compounds are com- 
pared with those of K2 diacetate in Table 10. 
Table 9. / 
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Table 9. Molecular rotation contribution of hydroxyl groups at position 
16 in 17- oxosteroids. 

















minus 17 -one 
+5 (E) 
16a- hydroxy -androst- 292 +194 +566 
4- ene -3:17 -dione (2) +44 (C) 
Androst-4- ene -3:17- 276 +189 +522 
elione (3) 
16a- hydroxyoestrone 286. +178 +509 
(4) +2 (E) 
Oestrone 270 +188 +507 
(5) 
16a- acetoxy -17 -one 
minus 17 -one 
K2 diacetate 388 +22.9 +89 +76 (E) 
Dehydroepiandro- 330 + 3.9 +13 
sterone acetate (1) 
3ß:16a-diacetoxy- 390 +57.1 +223 
5a-androstan-l7-one (6) -6 (C) 
3ß-acetoxy-5a- 322 +69 +229 
androstan-17-one (7) 
16a- hydroxyoestrone 370 +153 +566 
diacetate (4) +108 (E) 
Oestrone acetate 312 +147 +458 
(8) 
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16(3 -acetoxy -l7 -one 
minus 17 -one 
33: 16P-diacetoxy- 388 +6 +23 
androst-5-en-17-one (9) +46 (C) 
Dehydroepiandro- 330 -7 -23 
sterone acetate (10) 
Abbreviations: E = ethanol C = chloroform 
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Table 10. Comparison of some physical properties 
of K2 diacetate with those of two 




3ß :16(3-diacetoxy- 3p :16a-diacetoxy- K2 diacetate 
androst-5-en- androst-5-en-17-one 
17-one 
165(sinters), 167-168 167-171 
180-181 
+6 (CHC13 ) -18 (=la) +22.9 (EtOH) 
Since the optical rotation of a compound 
measured in ethanol is more dextro rotatory than 
when measured in chloroform (Barton and Klyne, 
1948) it is not possible to reach any conclusion 
regarding the configuration of the 16- hydroxyl 
group from the information available. The melting, 
point evidence would perhaps suggest the 16a- 
configuration. 
It has been shown that 16- oxooestradiol 
reduces BT as quickly and as strongly as do the 
C21 a- ketols (Touchstone, 1955; Colas, 1955). 
It was therefore expected that compounds containing 
the 16- hydroxy- 17 -keto grouping would reduce BT 
in/ 
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in a similar manner and Dried, Thoma, Pearlman, 
Herz and Borman (1955) have reported that 16a- 
hydroxyandrost- 4 -ene- 3:17 -dione reduced both 
Tollen's reagent and BT. A small amount of this 
compound was obtained from Dr Fried and the re- 
duction of BT by 50 P g. of 16a -hydroxyandrost -4- 
ene -3:17- dione, 50 µg. of 16- oxooestradiol and 
25 A g. of 11- deoxycortisol compared. These 
amounts of steroids were applied to filter paper 
and sprayed with the BT reagent. 16- 0xooestra- 
diol and 11- deoxycortisol reacted immediately and 
the intensity of the colour produced by 16 -oxo- 
oestradiol was about double that produced by 11- 
deoxycortisol. 16a- Hydroxyandrost- 4- ene -3 :17- 
dione reacted slowly and the final colour produced 
was similar to that given by 3 µg. of 11- deoxy- 
cortisol. Thus when the BT reaction is performed 
on paper the 16- hydroxy -17 -oxo group has only 
5-10 of the reactivity of the 17 -hydroxy -16 -oxo 
group or the 21 hydroxy -20 -oxo group. When the 
BT reaction is performed in solution the reactivity 
of the 16- hydroxy -17 -oxo group appears to be 
greater since under the alkaline conditions of 
the reaction the 16- hydroxy -l7 -oxo structure is 
partly transformed to the 17- hydroxy -16 -oxo 
structure; 
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structure (vide Section 11). Considering the 
above evidence the reduction of BT by purified 
preparations of K2 could be due to K2 itself and 
not caused by any contaminant. In this case K2 
and Xa would be identical. That neither of the 
samples of K2 obtained by Colas reduced BT can be 
attributed to the fact that the amounts of K2 
tested were too small. Of the second sample only 
21 4g. were used and this would therefore reduce 
BT to the same extent as only 1 -2 4g. of a 021 a- 
ketol. This amount is at the limit of sensitivity 
of the reaction for more than 2 µg. per cm.2 of a 
021 a ketol are needed to give a positive reaction 
(Bush, 1954). 
One difficulty with the acceptance of the 
structure 3p :16-- dihydroxyandrost- 5 -en -17 -one for 
K2 was the production of formaldehyde on oxidation 
as previously recorded. Then this oxidation was 
repeated in triplicate on another batch of K2 no 
formaldehyde was produced. When the residue 
(weight 8 mg.) from the mother liquors of a K2 
crystallization was chromatographed on a 100 x 
2 cm. column of Celite using the system benzene: 
hexane :methanol:water, 6 :4 :7:3 crystalline K2 was 
present/ 
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present in those fractions collected between an 
eluate volume of 960 to 1440 ml. and it was shown 
by paper chromatography that all the BT reducing 
material was also present in these fractions. 
Thus it was considered that K2 and 1a were 
identical. It remained to prove the presence of 
the ketol structure in ring D and to determine the 
configuration of the 16 hydroxyl group. 
11. Sodium borohydride reduction of K2. 
The first published report on the use of 
sodium borohydride as a reducing agent was that of 
and Brown (1949) and since then it has 
been used quite extensively in the carbohydrate 
field. It readily reduces aldehydes and ketones, 
and reductions follow the same pattern as those 
brought about by lithium aluminium hydride. However 
it is not quite as active as the latter reagent 
and thus permits the selective reduction of ketone 
groups in the presence of other functional groups. 
Moreover sodium borohydride has the advantage that 
it can be used in aqueous or methanolic solutions 
whereas lithium aluminium hydride must be used 
in non-hydroxylic solvents and protected from 
moisture. In the steroid field sodium borohydride 
was/ 
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was first used by Dauben and 75astham_ (1951) for 
the reduction of cholestenone enol acetate to 
cholesterol. 
If K2 had the structure 4:16a- dihydroxy- 
androst- 5 -en -17 -one then reduction by sodium 
borohydride should produce androst- 5- ene- 3É, :16a: 
17Ç- triol. A sample of K2 (wt. 15 mg.) was 
reduced by the method described by Norymberski 
and Woods (1955). To the K2 dissolved in 5 ml. 
of methanol 6 mg. of sodium borohydride were added 
and the mixture left at room temperature for l 
hr. At the end of this time the mixture was 
diluted with 50 ml. of water, 5.5 ml. N -HC1 added 
and the solution extracted with chloroform. The 
white residue (14 mg.) obtained from evaporation 
of the chloroform was crystallized from methanol - 
benzene to give 13 mg. of crystals. When the 
melting point was determined in an evacuated tube 
sublimation of the material occurred and the 
melting point of the sublimate was much lower 
than that expected for androst-5-ene-33:16a:17p- 
triol. Since the product appeared to be a 
mixture it was chromatographed on a Celite column 
using the solvent system benzene :80 methanol. 
However no separation was obtained and the combined 
residues 
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residues (12.1 mg.) were acetÿlated. The acetate 
was crystallized from hexane -ethyl acetate to give 
white fern -like crystals r :which melted at 209 -210 °C. 
Since the triacetate of androst-5-ene-30;16a;17r- 
triol melts at 189- 191 °C. this coríipound and the 
reduction product could not be identical. It 
could however be the triacetate of androst- 5 -ene- 
30:16(' :170 -triol which has been reported to melt 
at 203 -209 °. (Huffman and Lott, 1949), 214 -215° 
(Stodola, Kendall and McKenzie, 1941) and 224 -226° 
(Butenandt, Schmidt -Thomé and `TFeiss, 1939) . The 
weight of the crystalline compound obtained was 
not determined but it must have accounted for at 
least 50_ of the reduction product. 
Thus it could be that the 16- hydroxyl group 
that it was assumed occurred in K2 had the p con- 
figuration. Cooley, Ellis, Hartley and Petrow 
(1955) have reported that 3`,:16p- diacetoxy- androst- 
5 -en -17 -one and ,74:16a- diacetoxy -androst- 5- en -17- 
one are converted by standing in alkali to 4:170p- 
diacetoxy- and.rost- 5 -en -16 -one which is the more 
stable compound. Reduction of a 16 -oxo group by 
sodium borohydride gives a quantitative yield of 
the 16(x- hydroxy compound (Huffman and Lott, 1955). 
Marrian and Lake (personal communication) have 
shown/ 
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shown that when 16a hydroxyoestrone is allowed to 
stand in normal sodium hydroxide solution for 10 
min. 20¡% is converted to 16- oxooestradiol and this 
isomerization appears to be complete in about 2 
hr. Since solutions of sodium borohydride are 
alkaline ii, was possf_ble If K2 was 3ç3;16a- 
dihj droxy- androst- 5 -en -17 -one it was partially 
isomerized to 4:17(?- dihydroxy -androst- 5- en -16- 
one during the reduction. Reduction of the former 
compound would produce androst-5-ene-33:16:17ç- 
triol and reduction of the 16 -oxo compound would 
produce androst- 5- ene- 3p:16p :17Ç- triol. Since 
the sodium borohydride reduction took place over 
12 hr. and the sodium borohydride was added 
gradually in small amounts it is quite possible 
that some isomerization occurred. However Marrian 
and Loke have also shown that when 16a- hydroxy- 
oestrone is reduced with sodium borohydride over a 
period of 1 hr. 80' of an oestriol -like compound 
and 20;; of an epioestriol -like compound are pro- 
duced. The minor reaction product has not yet 
been identified so that it could be either 16- 
epioestriol or 17- Iioestriol. Thus the isolated 
compound resulting from the reduction of K2 could 
likewise/ 
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likewise be either and _cost- 5- ene -3ç :16r':17p -tri of 
or androst- 5- er_e- 3p :16a :17a- triol. Although the 
smelting point of the compound isolated was similar 
to that of the triacetate of androst- 5- ene- 3p :16p: 
17( -triol the melting point of the triacetate of 
androst- 5- ene- 3 :16a :17a -tri of is unknown and as 
recorded above the -ceiling points recorded for the 
triacetate of androst- 5- ene- 3p :16p:17p -triol vary 
widely. From the sodium borohydride reduction of 
K2 therefore it was not possible to draw any con- 
clusions regarding the structure of K2. Proof 
of the configuration of the 16- hydroxyl group in 
K2 could best be obtained by catalytic reduction 
of K2. 
12. Catalytic reduction of K2. 
In order to complete the identification of 
K2 a large pool of urine (1300 litres) was 
fractionated and the amount of K2 obtained, after 
crystallizing once from methanol, once from benzene 
and drying to constant weight, was 48 mg. The 
melting point of this sample of K2 was 176 - 177 °C. 
when determined on the hot -stage microscope 
apparatus and 177 -181 °C. when determined in an 
evacuated capillary tube. 
For the quantitative catalytic reduction of 
K2/ 
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K2 a Towers micro -hydrogenation apparatus was 
used. Grasshof (1934) and Butenandt and Dannen- 
baum (1934) have shown that a double bond in a 
steroid molecule can be reduced by using a 
palladium catalyst and that an oxo -group in the 
same molecule is unaffected. When 10.02 mg. of 
K2 were reduced in glacial acetic acid using a 
palladium black catalyst prepared as described by 
Willsttter and Waldschmidt -Leitz (1921) the 
corrected hydrogen uptake was 0.719 ml. Assuming 
K2 to have the structure 3:16-dihydroxyandrost-5- 
en -17 -one the calculated hydrogen uptake for 
reduction of the double bond was 0.738 ml. The 
reduced K2 was isolated by partitioning the acetic 
acid solution between chloroform and 5iß (w /v) 
sodium carbonate solution. The chloroform was 
then washed, dried and evaporated as described 
previously. 
It has been shown that using platinum oxide 
as catalyst both double bonds and ketone groups in 
the steroid molecule can be reduced (Shoppee,1940; 
Sarett, 1947). Using a platinum oxide catalyst 
prepared according to Adams, Voorhees and Shriner 
(1946) the corrected hydrogen uptake for the 
hydrogenation of 9.854 mg. of K2 was 1.41 ml. and 
the calculated value was 1.45 ml. The semi - 
reduced/ 
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reduced K2 of the first experiment was hydrogenated 
using the platinum oxide catalyst and the two 
samples of fully reduced K2 were combined. 
Thus the results of the hydrogenation were 
in accord with the presence in K2 of a double bond 
and a ketone group. 
The reduced K2 was crystallized from 
benzene- methanol but the determination of the 
melting point (220 -230 °C.) of the crystals 
obtained suggested that these were impure. The 
melting point of the expected product, 5c- 
androstane- 3C:16a:17P- triol, is 257 -259 °C. The 
crystalline product and its mother liquors were 
combined (wt. 16.7 mg.) and treated with 3 ml. of 
anhydrous acetone saturated with hydrogen chloride 
so that any compound with the hydroxyl groups 
attached to carbon atoms 16 and 17 in the cis- 
relationship would form an acetonide. After 
standing at room temperature for 30 min. the 
acetone solution was diluted with about 10 vol. 
of ice and water. The insoluble material which 
separated was filtered off, washed with water and 
dried. To separate the acetonide, if any, from 
the unreacted alcohol the residue was leached with 
benzene (twice with 3 ml.) until there was no 
fur ther/ 
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further decrease in weight. The residue obtained 
from evaporation of the benzene weighed 7 mg. The 
benzene -insoluble material - a white powder - was 
considered to be impure as judged from its melting 
point (225- 235 °C.) and it was therefore acetylated. 
The acetate was twice crystallized from 66; 
aqueous methanol and 6.7 mg. of white crystals 
of melting point 172 -174.5 °C. were obtained. The 
melting point of a mixture of the acetate from 
the reduced h2 and the triacetate of 5a- androstane- 
3(3 : 16a,:17ß -triol was also 172- 174.5 °C. Thus it 
seemed reasonable to conclude that the hydroxyl 
group attached to carbon atom 16 had the a con- 
figuration so that K2 had the structure 3:16a- 
dihydroxyandrost- 5 -en -17 -one. 
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13. The nature of the formaldehydogenic 
substances liberated by boiling. 
Since Xa and K2 had been shown to be 
identical it was necessary to enquire into the 
nature of the formaldehydogenic substances (FSS) 
liberated by boiling. The residue obtained 
from a chloroform extract of urine which had 
previously been extracted and boiled was treated 
as shown below: - 
Residue dissolved 
in 60 ml. of 
chloroform 
2x5m1. used for A 
(determination of FSS 
30 ml. used for 
'partition procedure: - 
(i Hexane phase B 
(ii Methanol phase C 
iii Ether phase D 
'20 ml. used for 
Girard separation: - 
(i Ketonic fraction E 
(ii Non -ketonic fraction F 
The residues obtained from fractions B to F were 
each dissolved in 10 ml. of chloroform and two 
aliquots of 5 ml. from each fraction used for the 
determination of FSS. The results are shown in 
Table 11. Thus while little of the FSS is lost 
in the partition procedure about half of the FSS 
is lost during the Girard separation. The Girard 
separation was performed according to the method 
described. in Section 2 where the Girard hydrazones 
are/ 
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A B C D E F 
0203 .000 .124 .432 .098 .099 
.207 .000 .127 .432 .094 .096 
32.7 0 6.6 23.4 8.0 8.0 
are only hydrolysed for a period of 2 hr. The 
low yield of FSS after the Girard separation 
could have been due to incomplete hydrolysis. The 
equal distribution of FSS between the ketonic and 
non -ketonic fractions might have been due to the 
ketonic material reacting with difficulty with 
Girard's reagent. When the Girard separation was 
repeated on another boiled urine residue a result 
similar to that in the experiment above was 
obtained. Lengthening the period of hydrolysis 
by 20 hr. did not release any more FSS. When one 
half of the non -ketonic fraction was again sub- 
jected to the Girard separation no FSS entered 
the ketonic fraction showing that the ketonic 
material present in the original extract had no 
difficulty in forming a hydrazone. The loss of 
half of the FSS during the Girard separation 
could be attributed to the acid used for hydrolysis 
of/ 
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of the Girard complex. 
Two aliquots, each 1/6 of the residue from 
a chloroform extract of pre- extracted boiled 
urine, were used for the determination of FSS. 
The remainder of the residue was divided into 
two equal parts, each dissolved in 10¡b aqueous 
methanol, acidified to pH 1 and allowed to stand 
at room temperature. One half was extracted 
after 2 hr. and the other after 20 hr. and 
duplicate determinations of FSS performed on 
each extract. The results obtained (Table 12) 
showed that about half of the FSS released by 
boiling was destroyed by standing at pH 1 at 
room temperature for 2 hr. 
Table 12. Lability of FSS liberated by boiling. 
Time at Spekker Readings FSS 
H i 
) 
(pg. HCHO per litre') 
(hr. 
0 .112, .110 17.8 
2 .080, .076 10.6 
20 .075, .081 10.6 
Chromatography of an extract of 5 litres of 
pre- extracted boiled urine on Celite using the 
solvent mixture benzene:80% aqueous methanol 
suggested that most of the FSS released by 
boiling/ 
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boiling was not steroidal. Nine fractions each 
containing 50 ml. of eluate were collected and 
1/3 of each fraction chromatographed on paper 
using system B5M. One third of each fraction was 
also used for the determination of FSS and the 
values obtained are shown in Table 13. The paper 
chromatograms showed Compound X to be present in 
fractions 3 and 4 and the only other BT reducing 
material present was Compound Y in fractions 4 
and 5. Thus the main band of FSS is slightly 
less polar than Compound X. 

























If the major part of the formaldehydogenic 
material released by boiling i.e. that in 
fractions 2, 3 and 4, is steroidal then it is 
possible to make suggestions regarding its 
structure. Since Compound X, 5G- pregnane- 3a:17a: 
20a -triol and 11- deoxycortisol all have a similar 
polarity the main band of FSS would be slightly 
less polar than these compounds. Since the 
material/ 
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material is formaldehydogenic but not BT reducing 
an a- glycol side -chain may be present and its 
release by boiling would suggest that it arose 
from the sulphate of a steroid with a 5 -en -313 -ol 
group. 3:5- 0yclo- pregnane -63:20:21 -triol would 
be of similar polarity to X and this structure 
would be a possible one for the FSS released by 
boiling. Another possibility would be for the 
material to be a ring A artifact of a steroid 
with a 20:21 glycol group or a mixture of such 
steroids. It is also probable that the released 
material is not steroidal. 
14. Discussion. 
It seems certain from the evidence reported 
here that K2 has the structure 33 :16x- dihydroxy- 
androst- 5 -en -17 -one ( 16x- hydroxydehydroepiandrosterone). 
K2 and 16a- hydroxyoestrone (G. F. Marrian, personal 
communication) are the first steroids with the 
16- hydroxy- l7 -oxo group to be isolated from natura_ 
sources. Steroids containing this group were 
unknown until the synthesis of 33:16a- dihydroxy- 
5a- androstan -l7 -one and 16a- hydroxyoestrone di- 
acetate by Leeds, Fukushima and Gallagher (1954). 
Since K2 cannot be extracted from unboiled urine 
by chloroform it must be excreted in a conjugated 
form/ 
-101- 
form. From a consideration of its structure 
and biy analogy with dehydroepiandrosterone (DHA) 
this conjugated form is almost certainly the 3p- 
sulphate. Unfortunately the amount of K2 excreted 
per day is unknown. A minimum value would be 
about 200 pg. per day. Since hydrolysis of the 
conjugate of K2 was not complete under the con- 
ditions employed and since the intensity of the 
colour produced by K2 in the blue tetrazolium 
reaction was less than the intensity of the colour 
produced by an equal amount of a C -21 a- ketolic 
steroid such as cortisol or 11- deoxycortisol which 
has been used as the reference compound it is 
possible that the amount of K2 excreted per day is 
greater than the value given above. The fact that 
K2 has not previously been isolated is no doubt 
due to the methods of hydrolysing urinary steroid 
conjugates which have been used. It has been 
shown in Section 4 that K2 is destroyed by heating 
with acid. When the method of continuous ex- 
traction at pH 1 is used it is probable that some 
K2 is destroyed by prolonged standing in acid 
solution in the presence of other urinary con- 
stituents or that some K2 is oxidized by the 
possible presence of peroxides in the ether used 
for/ 
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for the extraction. The mode of hydrolysis - 
boiling at neutral pH - used by Dingemanse et al. 
(1952) would have hydrolysed the conjugate of K2 
but these investigators were using the Zimmermann 
reaction for estimating urinary 17- oxosteroids and 
since K2 does not react in the Zimmermann test it 
would not have been detected. 
So far few steroids containing the 5- en -3R -ol 
group have been isolated from urine. Those that 
x 
have are listed in Table 14 which also records 
some of the physical properties of the compounds. 
The values given are considered to be the most 
accurate available and are selected from a 
collection of all the values reported in the 
literature both for the isolated and synthetic 
steroids. Only two, DHA and androst- 5- ene- 3P:16a: 
17(3- triol, have been isolated from the urine of 
normal people. 
It has been shown that K2 is a metabolite of 
DHA. When 100 mg. of DHA were administered to an 
adr_enalectomized ovariectomized women about 2% was 
excreted as Compound X and 1% as Compound Y and 
none of these compounds were detected in control 
samples of urine collected before or after the 
administration of DHA. Structurally K2 is 
intermediate/ 
x 
See Appendix II. 
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intermediate between DHA and androst-5-ene-313:16a: 
17(3 -triol although whether K2 arises by 16- 
hydroxylation of DHA or by oxidation of the hydroxy 
group in position 17 of androst-5-ene-3P:16a:173- 
triol is not yet known. 
From the urine extracts from which K2 has been 
isolated androst- 5- ene- 31:16a:17Ç -triol has also 
been isolated (see Appendix I). This compound has 
once previously been isolated from normal urine by 
Marrian and Butler (1944) who employed acid hydroly 
of the urine. The minimum value found for the ex- 
cretion of the compound was 100 µg. per 24 hr. The 
amount of this compound detected in the present 
investigation was also about 100 'g. per 24 hr. an 
as in the case of K2 this is possibly a minimum 
value. Thus in addition to DHA normal urine con- 
tains two metabolites of DHA with the 5- en -3p -o1 
group and the amounts of these two metabolites 
excreted may be quite large. If so the amount of 
DHA produced per day is greater than is usually 
measured. 
Considered from a quantitative point of view 
DHA is one of the three most iirijiortant 1 ? -keto- 
steroids in normal urine. Prior to 1951 only a 
fraction of the DHA present in urine was estimated 




hydrolysis. Recent values suggest that between 
1 mg. and 5 mg. of DHA are excreted per day and 
this accounts for 15% to 30% of the total 17 -keto- 
steroid excretion. The values reported by various 
authors for normal urine are listed in Table 15. 
The last column records the method of estimation 
used. The Pettenkofer reaction and Zimmermann 
reaction have already been described in this 
thesis. Those investigators using the Pettenkofer 
reaction performed this reaction on the ketonic 
fraction after a Girard separation. Ronzoni used 
a modified Kober reaction developed by Allen, 
Hayward and Pinto (1950) and supposed to be 
specific for DHA and applied this reaction to the 
residue obtained after continuously extracting 
urine, acidified to pH 1, for 48 hr. Dingemanse 
et al. separated the 17- ketosteroids chromato- 
graphically while Cohen and Oneson used the buffer 
hydrolysis method. Dobriner performed a digitonin 
precipitation on the residue from a continuous 
extraction of urine. For comparison Table 15 also 
records the daily excretion of androsterone (3a- 
hydroxy- 5a- androstank -l7 -one) and etiocholanolone 
(3a,- hydroxy- 5lß- androstant -17 -one), the two other 
17- ketosteroids present in urine in large amounts. 
Thus/ 
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Table 15. Amount of dehydroepiandrosterone 
present in the urine of normal humans. 
Authors Male Amount % of total 
or detect- 17 -keto- 
Fem- ed steroids . 




Landau et al. M 
and 
F 
1-12.4 10-60 Pettenkofer 
(1951) 
Dingemanse, Huis. M 0.7- 8 -41 Zimmermann 
int t Veld & 8.6 
Harto h -Katz. F 0.2- 1 -29 (1952) 
4.9 
Ronzoni M 2.2- 15-26. Allen 
(1952) 5.0 
Bray & M 4.4+ 32.8+8.8 Pettenkofer 
Merivale 2.4- 
(1953) F 4.0+ 36.3+8.4 
1.5 
Prunt M 0.5-1.1 8-13 Pettenkofer 
(1953 F 0.3-1.4 17-23 




Dobriner M 1 -2 10 -20 Zimmermann 
(1954) 
Sub in,Dorfman M 3.4 28 Androsterone 
& Pincus 3.9 32 Etiocholanolone 
(1954) F 3.8 30 Androsterone 
3.0 27 Etiocholanolone 
-106- 
Thus the amount of DHA excreted by females is 
only slightly less than that excreted by males 
while it accounts for about the same proportion 
of the total 17- ketosteroids. 
It seems certain now that DHA is derived 
only from the adrenal cortex and can be used as 
an indication of adrenal activity (Mason and 
Engstrom, 1950; Landau, Knowlton, Lugubihl and 
Kenyon, 1951; Prunty, 1953). There is usually 
a very large increase in the excretion of DHA 
in the urine of patients with adrenocortical 
tumours (Crooke and Callow, 1939). Hirschmann 
and Hirschman (1947) isolated 315 mg. per litre 
of DHA from the urine of a boy with adrenocortica 
carcinoma and Mason (1948) isolated 613 mg. per 
litre in another case. In adrenal hyperplasia 
although the absolute amount of DHA may be 
increased an abnormally large proportion of the 
17- ketosteroids is not excreted in this form 
(Mason and Engstrom, 1950; Prunty, 1950). In 
addition the excretion of DHA is usually increase 
by the administration of ACTH. In the study of 
Ronzoni (1952) the excretion was approximately 
trebled in six out of seven cases. Dobriner(1954) 
found a 3- to 6 -fold increase in three out of 
four cases. Landau et al. (1951) found a 2- to 
4 -/ 
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4 -fold increase and Prunty (1953) a 2- to 10 -fold 
increase although in one case there was no increase. 
An increased amount of K2 was excreted after the 
administration of ACTH in the two cases reported 
in this thesis. 
Migeon and Plager (1954) have shown that 
DHA, probably present as the sulphate, is the most 
abundant 17-ketosteroid in blood. The amount in 
peripheral plasma of both males and females was 
about 40 pg. (Migeon, 1956a). There was a 
variability of response of plasma DHA to the 
intravenous infusion of ACTH (Migeon, 1956b) . An 
increase was found 4 to 6 hr. after the beginning 
of the infusion whereas the 17 hydroxycortico- 
steroids reached their maximum concentration after 
2 hr. It was suggested that the adrenal secretes 
a steroid other than DHA which Was later metabolized 
to DHA. 
While there is much evidence that DHA or its 
precursor originate in the adrenal cortex it is 
certain that little or no DHA arises from the 
testes. DHA is known to occur in the urine of 
gonadectomized men and women. It is reported not 
to occur in the urine of patients with an inter- 
stitial cell tumour of the testes (Prunty, 1950; 
Venning/ 
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Venning, 1952a). Landau et al. (1951) found no 
increase in the excretion of Pettenkofer chromogen6 
after the injection of 14,000 i.u. of chorionic 
gonadotrophin over a 6 day period to two normal 
young men although their 17 ketosteroid excretion 
was doubled. DHA excretion is not increased by 
the administration of testosterone (West, Reich 
and Samuels, 1951; Dobriner and Lieberman, 1950; 
Landau et al., 1951) and Fukushima, Bradlow, 
Dobriner and Gallagher (1954) found that after the 
intravenous infusion of labelled testosterone the 
DHA isolated from the urine was unlabelled. 
Up to the present time DHA has not been 
isolated from adrenal glands. It would be of 
interest to determine whether this steroid could 
be extracted from the 
tumours. 
blood of 
adrenals in cases of adrenal 
DHA has been isolated from adrenal vein 
a girl with virilism (Bush, Swale and 
Patterson, 1956). Bloch, Dorfman and Pincus 
(1956) have shown that human adrenal gland slices 
will convert C14- labelled acetate to DHA. 
T;lason and Kepler (1945a) showed that after 
giving 1 g. of DHA over 16 days to a man with 
anterior pituitary insufficiency the DHA isolated 
from urine constituted 20% of the 17-ketosteroids 
isolated; they also isolated 20 as 3a hydroxy- 
5 f, _/ 
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5p- androstan -l7 -one, 35% as 3a hydroxy -5a- 
androstan -17 -one and as androst- 5- ene- 33:17('- 
diol. Similar, results have also been reported by 
Mason and Kepler (1947), Hiller, Dorfman and 
Miller (1950), and Landau et al. (1951). Ungar, 
I\iller and Dorfman (1954) isolated DHA, 3a hydroxy 
5[ -androstan -l7 -one, 3a- hydroxy -5a- androstan -l7- 
one and. 3a: 17 (3- di'_hydroxy- 5f- androstane from the 
urine of a man who received androst-5-ene-3p:17(3- 
diol. Dorfman (Dorfman and Shipley, 1956) has 
reported that 3p:17a- dihydroxy.i,pregn- 5 -en -20 -one 
administered to humans is converted to DHA whilst 
Lieberman (1956) obtained no evidence for this 
reaction in vivo. Since no details have been 
published of either of these experiments it is not 
possible to arrive at any conclusion. 
Thus except for DHA, androst-5-ene-3p:17p- 
diol and ACTH no other substance increases DHA 
excretion. If endogenously produced DHA is 
metabolized in the same way as administered DHA a 
large amount of the androsterone and etiocholanolon 
in urine must come from DHA and DHA and its 
derivatives would thus account for the major portio 
of 17 '4*etosteroids of adrenal origin. 
The/ 
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The results from in vitro studies have 
agreed with those obtained in vivo. Schneider 
and T"ason (1948) found that DOHA incubated with 
rabbit liver slices was converted to androst -5- 
ene- 3f :17; -.diol and androst- 5 -ene- 3(ß:16a :17 p,- 
triol.. Ungar, Miller and Dorfrlan (1954) showed 
that perfusion of DHA through rat livers produced 
androst- 5 -ene- 3.:17ç -diol and androst-4-ene-3:17- 
di.one. After perfusion of DITA through beef 
adrenals 11[3 - by °dro j-- androst -4- ene -3 :17 -dione was 
isolated (Meyer, Jeanloz and Pincus, 1953), and . 
following the incubation of DHA with bovine adrenal 
homogenates Meyer, Hayano, Lindberg, Gut and Rodgers 
(1955) detected 28 different compounds. One half 
of the DHA was unmetabolized and other steroids 
with a 5- en- 3(Ç -ol group, if present, were present 
in only trace amounts. Androst -4- ene -3:17 -dione 
and 11(x- hydroxy- androst-- 4 -ene- 3:17- dione were the 
rain -netabolites. Samuels, Helmreich, Lasater and 
Reich (1951) have shown that endocrine glands that 
produce steroids contain an enzyme 4- ol- dehydrogen 
ase which converts the 5- en -3p -ol group of steroids 
the 4- ene- 3 -keto group. From the work of Ungar, 
v"iller and Dorfman (1954) it appears that this 
enzyme also occurs in rat livers. 
The;' 
The metabolism of DHA, resulting from in 
vivo and in vitro studies, has been summarized by 
Dorfman (1953). Some is excreted unchanged whilst 
a greater amount is converted to androst- 4 -ene- 
3 :17 -dione which in turn is metabolized to andro- 
sterone and etiocholanolone. Small amounts of 
DHA are converted to androst- 5- ene- 4:16a :173- 
triol and possibly trace amounts are converted to 
androst- 5- ene- 3(ß, :17p -diol. The present work has 
shown that K2 is an important metabolite of DHA. 
Although the metabolism of DHA, is now well 
known little is known concerning the origin of 
DHA. 
Marker (1938, 1941) suggested that the 5- 
en -3p -ol group arose from the 4 -en -3 -one group but 
evidence from experiments in which steroids with 
the 4 -en -3 -one group have been administered to 
people would seem to disprove this suggestion. The 
main metabolic reaction for the 4 -en -3 -one group 
is reduction to the saturated alcohol. However 
Munson, Labhart and Forsham (1952) reported that 
the administration of 100 mg. per day of cortisol 
or cortisone to three adrenalectomized gonadecto- 
mized men increased the amount of Pettenkofer 
chromogens excreted. After the administration 
of/ 
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of cortisone the DHA excreted accounted for 40; 
of the urinary 17-ketosteroids but after adminis- 
tration of cortisol the figure was only 6;. These 
findings are hard to accept for so far there is 
no evidence that an oxygen atom at position 11 in 
the steroid molecule can be removed. It is also 
known that in congenital adrenal hyperplasia 
administration of cortisone reduces the excretion 
of 17-ketosteroids and DHA (Gardner and Migeon, 
1952). ' ;olfson, Eya and Robinson (1952; Wolfson, 
1954) also suggest that the 5- en -3p -ol group arise 
from the 4 -en -3 -one group and further suggest that 
corticosterone is the major source of Pettenkofer 
chromogens in urine. Although the excretion of 
DHA was not increased by injection of cortico- 
sterone the excretion of three other Pettenkofer 
chromogens, of unknown nature, was. 
DHA could be derived directly from 
cholesterol. Hirschmann and Hirschmann (1945, 
1947) have suggested that the reaction between 
17-ketosteroids and C -21 steroids can proceed in 
both directions and that DHA, may be formed from 
cholesterol without passing through a C -21 
intermediate. 
the/ 
Thus in cases of adrenal tumours 
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the conversion of cholesterol to DHA is supposed 
to proceed at a rate that is greater than the 
conversion of DHA to other compounds so that DHA 
is released in large amounts from the adrenal 
cortex. That the large amounts of DHA found in 
the urine of patients with adrenal tumours is not 
due to saturation of the enzyme systems involved 
in its conversion has been shown by Mason and 
Kepler (1947). When 1.2 g. of DHA was administered 
over eight days to a woman with an adrenal tumour 
and whose 17-ketosteroid excretion averaged 250 mg. 
per day there was only a small increase (19 mg.) 
in the average 17-ketosteroid excretion and no 
change in the pattern of steroid excretion. 
Another possible route for the synthesis 
of DHA would involve a direct synthesis from 
acetate without cholesterol being an intermediate. 
Such a possibility has been suggested by Brady 
(1951) and by Stone and Hechter (1954) but more 
evidence is needed to support this scheme. 
Since cholesterol is present in the adrenal 
in large amounts and since it has the 5- en- 3p -o1 
group which occurs also in DHA, it has received 
most attention as a precursor of DHA. The scheme 
for which most evidence is available involves the 
conversion of cholesterol to a C -21 steroid which 
then/ 
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then has the side -chain removed. It is known from 
the use of radio- active cholesterol in vivo and in 
vitro that cholesterol is a precursor of the C -21 
steroid hormones (see Hechter and Pincus, 1954). 
The scheme postulated by Hechter and Pincus for the 
biosynthesis of corticosteroids is shown in Fig.14. 
Pregnenolone (4 hydroxy- pregn- 5 -en -20 -one) has 
now been isolated from cow adrenal homogenates 
incubated with cholesterol (Saba, Hechter and 













Fig. 14. Scheme of corticosteroid biosynthesis. 
17 -deoxy C -21 steroids can be converted to C -19 
steroids the pregnenolone formed would have to 
undergo 17 hydroxylation before it could be 
converted/ 
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converted to DHA and an active 17 hydroxylase is 
known to occur in the adrenal. Removal of the 
side -chain would give DHA. This is the scheme 
suggested by Lieberman and Teich (1953). 
It is possible that there are two main 
pathways for the pregnenolone that is produced 
in the adrenal. The main one is its conversion 
to progesterone by the enzyme 3p -ol- dehydrogenase; 
the second is hydroxylation by the enzyme 17- 
hydroxylase. The progesterone produced is then 
hydroxylated at C -17 and further hydroxylated to 
cortisol - reactions which have been studied in 
vitro. If however the 3p-ol-dehydrogenase has a 
low affinity for 17- hydroxypregnenolone this 
steroid would tend to accumulate and could be con- 
verted to DHA. To account for the effect of ACTH 
it is assumed that this increases the activity of 
the 17 hydroxylase thus increasing the amounts of 
17 hydroxyprogesterone and 17-hydroxypregnenolone 
formed. In cases of adrenal tumours it is 
necessary to postulate that the cells, which appear 
to be autonomous, lack the 4-ol- dehydrogenase or 
have an extremely active 17- hydroxylase. The cells 
of adrenal tumours do not appear to differ histo- 
logically in most cases from normal adrenocortical 
cells/ 
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cells (Cahill, 1944). 
With regard to the action of ACTH Stone 
and Hechter (1954) suggested that this hormone 
increases the conversion of cholesterol to 
pregnenolone. However there is some evidence that 
the enzyme 17- hydroxylase may also be affected. 
After hypophysectomy the zona glomerulosa appears 
to remain normal while the zona fasciculata 
atrophies and after the administration of labelledi 
ACTH the labelling is localized in the zona 
reticularis. Ayres, Gould, Simpson and Tait (1956) 
have shown that there is a differential production 
of corticosteroids in the ox adrenal gland. The 
zona fasciculata contained mainly cortisol and 
little aldosterone whereas the zona glomerulosa 
contained more aldosterone than cortisol. Kass, 
Hechter, Macchi and Mou (1954) found that the 
predominant corticosteroid in the adrenal vein 
blood of rabbits treated for 21 to 28 days with 
ACTH was cortisol whereas non- treated rabbits 
secrete corticosterone. In this case ACTH had 
changed the secretion from the 17 -deoxy to the 
17- hydroxy type of steroid. Hechter and Pincus 
(1954) have reported that the steer adrenal 
produces/ 
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produces primarily corticosterone and little or no 
cortisol and that the ability of the perfused 
steer adrenal to 17- hydroxylate progesterone is 
absent or minimal. TIacchi and Hechter (1554) 
found that perfused steer glands either failed or 
responded poorly to ACTH although the cortico- 
steroid production of perfused cow adrenals was 
greatly increased by the addition of ACTH to the 
perfusion fluid. It does appear therefore that 
ACTH has some effect on the enzyme 17-hydroxylase. 
Since the gonads and the adrenal cortex are 
derived from the same embryonic tissue it is 
probable that the first steps in the synthesis of 
the hormones of the different glands are the same. 
Slaunwhite and Samuels (1956) have shown that 
testes slices will convert progesterone to testos- 
terone and that 17 -k droxyprogesterone is an inter -i, 
mediate. An alternative pathway would be via 17- 
hydroxy pregnenolone and DHA. However if there 
is present in testes a large amount of 3p -ol- 
dehydrogenase compared to the amount of 17- hydroxy- 
lase then almost all the pregnenolone formed would 
be oxidized to progesterone. If this scheme is 
correct it could be that gonadotrophin acts to 
accelerate the last stage of the synthesis - the 
reduction/ 
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reduction of androst- 4 -ene- 3.17 -dione to 
testosterone (17- hyâroxy- androst- 4 -en -3 -one). 
The equilibrium in vivo between 17-ketosteroids 
and C -19 17hydroxysteroids _savours very much the 
17-ketosteroids. 
If the synthesis of steroids takes place 
by the same route in all steroid producing tissues 
then it would be expected that steroids which are 
i ntern?ediates in the synthetic process, or co- 
pounds derived from these, =^could be coml'on to all 
the steroid producing organs. Thus progesterone 
has been isolated from ovaries, adrenals and 
placentae, 3 hydroxy- 5a- pregnan -20 -one from 
ovaries, adrenals, placentae and testes and 3a- 
hydroxy- 5a- pregnan -20 -one and 3p, hydroxy- pregn- 
5 -en 20 -one from testes. 
The schemes proposed above suggest that 
DHA and the other 5- en- 3(s -ol steroids have no 
physiological activity and are merely intermediates, 
or derived from intermediates, in the synthetic 
process. DHA is weakly androgenic being about 
half as active as androsterone ( Fieser and Fieser, 
1049). It has no effect on nitrogen retention 
even when administered in large doses (Mason and 
Kepler, 1945a) nor has androst- 5- ene- 4:17Ç -diol 
(Albright / 
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(Albright, 1942). Pregnenolone is active with 
respect to spermatogenesis and prevents the 
testicular atrophy that normally follows hypo - 
physectomy (Albert and Selye, 1942; Masson, 1945). 
Polley and Mason (1950) did not observe any bio- 
logical effects when Pregnenolone and 21 hydro - 
pregnenolone were administered to humans with 
rheumatoid arthritis. Pregnenolone taken by 
mouth has been reported to enhance skilled psycho- 
motor performance and to be more active in this 
respect than cortin (Pincus and Hoagland, 1944). 
Whether or not DHA has any activity in the foetus 
is an interesting possibility. Read, Yenning and 
Ripstein (1950) showed that large amounts of 17- 
ketosteroids were excreted in the first two days of 
life followed by a downward trend. Migeon (1956 c) 
has confirmed these results and found that at six 
weeks of life the plasma DHA level was 8 -12 µg.% 
and that of androsterone 9 µg.;ß. These levels 
had fallen to zero after six months. The maternal 
DHA levels were lower than the levels in cord plasm 
and lower than the average for normal non- pregnant 
females. 
Considering the above facts it is not 
expected that K2 will have any physiological 
activity/ 
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activity. The finding of Speirs et al. (1951) 
that boiling urine without loss of volume increase 
its activity compared with unboiled urine in the 
eosinophil test will need reinvestigation. 
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PART II. 
COLD ACID -LABILE FORMALDEHYDOGENIC SUBSTANCES 
IN HUMAN URINE. 
-122- 
1. Introduction. 
It is well known that many steroids are 
transformed by being heated in acid solution. 
This part of the thesis is concerned only with 
substances which are labile to cold acid, i.e. 
transformed by standing in acid solution at pH 1 
at room temperature. The method of estimation 
used would detect those substances which give 
rise to formaldehyde after oxidation with periodic 
acid. Of the steroids only those containing a 
ketol or glycol grouping at positions 20 and 21 
are so oxidized. 
Paterson and Marrian (1953b) reported that 
formaldehydogenic substances (FSS) occur in 
normal human urine which lose their formaldehydo- 
genic properties on standing at room temperature 
in acid (pH 1) solution for two hours. The 
increased amounts of cold acid -labile PSS found 
in the urine of a patient injected with adreno- 
corticotrophic hormone (ACTH) suggested that 
such FSS probably originated in the adrenal 
cortex. The work described below was commenced 
in order to discover further properties of this 
FSS/ 
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FSS. However, the presence of cold acid- labile 
FSS in urine was not confirmed and it appeared 
that most, if not all, of the labile FSS detected 
by Paterson and Marrian originated in the solvents 
used for the extraction of urine. 
Heard, Sobel and Venning (1946) observed that 
when urine was acidified the amount of reducing 
substances which could be extracted by a chloro- 
form-ether mixture was greater than that obtained 
when the extraction was performed at neutral pH. 
Sixty per cent. of the reducing substances present 
were destroyed by standing for one hour at room 
temperature with 2 vols.% of concentrated 
su;phuric acid. When urine was neutralized 
immediately after acidification and then extracted 
the amount of reducing substances extracted was 
the same as that extracted from unacidified urine. 
Paterson, Cox and Marrian (1950) found that pre- 
liminary acidification also increased the amounts 
of formaldehydogenic substances which could be 
extracted from urine and these authors were the 
first to indicate the presence in human urine of 
FSS which was labile to cold acid. If urine, 
acidified to pI 1, was allowed to stand at 25° and 
aliquots withdrawn at various time intervals for 
the/ 
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TIME INTERVAL (h rs) BETWEEN ACIDIFICATION AND EXTRACTION (0), 
OR BETWEEN ACIDIFICATION AND NEUTRALIZATION BEFORE EXTRACTION(X ). 
FIG.I5. HYDROLYSIS CURVE OF URINE. 
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the determination of FSS then hydrolysis curves of 
the type shown in Fig. 15 were obtained. If the 
urine was neutralized immediately before extraction 
the values of FSS obtained are shown by crosses 
in Fig. 15. The results could be interpreted to 
mean that there were two groups of conjugated FSS; 
the ionization of one group - the chloroform 
soluble conjugates - was suppressed at pH 1 and 
the unionized form was thus extracted by chloro- 
form. When the urine was at neutral pH the 
conjugate was ionized and not extractable with 
chloroform. Since the effect of neutralization 
decreased with time it was supposed that complete 
hydrolysis occurred within the first two hours of 
acidification and the decrease in the amount of 
FSS extracted between two and four hours was due 
to destruction by acid of the liberated FSS. This 
conjugate was shown not to be a glucuronidate 
(Paterson and Marrian, 1951). The other group 
of conjugates - the chloroform insoluble conjugates 
was not extracted from acidified urine by chloro- 
form. The slow rise after four hours in the 
amount of FSS extracted from acidified urine was 
due to a slow liberation of FSS from chloroform 
insoluble conjugates. Further studies by Cox 
and/ 
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and Marrian (1951) on this latter group of con- 
jugates showed that when subjected to the action 
of a 1- glucuronidase preparation two different 
types of compounds were released. One type was 
slowly destroyed at pH 1 at room temperature 
whereas the other type was stable. 
In the experiments reported above the chloro- 
form extracts of urine were not washed with either 
alkali or water and Paterson and Ifarrian (1953a) 
have shown that such extracts will react with and 
retain added formaldehyde. Alkali- washed extracts 
of urine also have this property to a lesser 
extent and the formaldehyde retaining power may be 
increased by acid hydrolysis of urine at room 
temperature. When alkali- washed extracts of urine 
were used the presence of cold acid- labile FSS was 
not always indicated and there was a possibility 
that any apparent destruction of FSS was due to 
formaldehyde retention. To test this possibility 
methods of determining formaldehyde retention were 
elaborated by Paterson and Marrian (1953b) and 
experiments were performed on the same urine 
specimen to determine (1) the formaldehyde 
retaining capacity, (2) the FSS by direct oxidation 
with periodic acid, and (3) the FSS after 
formaldehyde/ 
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formaldehyde pretreatment at varying time intervals 
after acidification to pH 1. When corrected for 
formaldehyde retention it appeared that there was 
a destruction of FSS of between 2C to 30, during 
the first two hours after acidification. 
It was also shown that the cold acid -labile 
FSS was present in the unconjugated fraction 
rather than liberated by hydrolysis of conjugates. 
Acidification of chloroform extracted urine 
increased the amount of extractable FSS whereas 
acidification of the chloroform extract of urine 
caused a destruction of FSS which was complete in 
about one hour. Only a part of the total uncon- 
jugated FSS in urine was labile at pH 1 and room 
temperature. Values for cold acid-labile FSS 
ranged from 8.4 to 27.4 µg. formaldehyde per 24 
hour. 
Although nothing was known of the nature of 
this cold acid- labile material it was assumed to 
be steroidal and to originate in the adrenal 
cortex. In an experiment on a rheumatoid 
arthritic man injected with ACTH the excretion 
of the cold acid- labile FSS was increased and its 
excretion pattern was similar to that of the cold 
acid -stable unconjugated FSS and the hot acid - 
stable FSS, which are probably artifacts formed 
from/ 
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from the 02i 17- hydroxy -corticosteroids, and hot 
acid -stable acetaldehydogenic substances. 
2. Methods used. 
Two methods of determining cold acid- labile 
FSS have been used. 
Method 1. 
This method was used by Paterson and IvIarrian. 
One third of a 24 hr. specimen of urine was 
extracted twice with 2 vols. of chloroform. The 
combined chloroform extracts were washed twice 
with 1/5 vol. of 5; sodium bicarbonate solution, 
twice with 1/5 vol. of water, dried for about 10 
min. over anhydrous sodium sulphate A.R. and 
evaporated to dryness under reduced pressure in 
a water bath at a temperature of less than 40 °C. 
The residue was dissolved in 2 ml. ethanol, 
diluted to 100 ml. with water and divided into 
two ecáual parts. Both parts were acidified to pH 
by adding 5.5 ml. of N -H2 S0g . One part was ex- 
tracted immediately after acidification and the 
other after standing at pH 1 for 1 hour. Each 
part was extracted twice with 2 vols. chloroform 
and the chloroform extracts washed, dried and 




dissolved in 1.5 ml. ethanol and two 0.5 ml. 
portions oxidized for the determination of FSS. 
In later experiments, to avoid the use of ethanol, 
the final dried chloroform extract was divided 
into two equal parts and each part evaporated to 
dryness. Each residue was transferred quanti- 
tatively by the use of chloroform to a distillatio 
flask (approximately 30 ml. capacity), the 
chloroform evaporated in vacuo and the last 
traces of chloroform removed by leaving the 
flask in an evacuated desiccator for 10 min. 
Each residue was then dissolved in 0.2 ml. 
glacial acetic acid. 
Method 2. 
A washed and dried chloroform extract of 
urine was prepared as described above and 
divided into two equal parts. To each part 20 
vols.% ethanol and 1 vol. 5M -H2SO4 were added, 
one part being washed immediately with alkali and 
water and the other after standing for one hour 
at room temperature. After drying each extract 
was divided into two equal parts and evaporated 
to dryness in vacuo at a temperature less than 
40°C. The residues obtained were transferred to 




Oxidation procedure, distillation of formaldehyde' 
and colour reaction. 
These were performed as described by Paterson 
and Ivarrian (1953a). To the urinary residue 
dissolved in ethanol or acetic acid was added 
sufficient water to make the volume up to 1 ml., 
2 ml. of a solution of in 0.4 N -H2 S0 were 
added and the oxidation allowed to proceed at 
room temperature for two hours. The oxidation 
was stopped by the addition of 3 ml. 28% ZnC12 
in 1.2 N-HC1. After adding 3 ml. 10N -H2 SO4 the 
oxidation mixture was distilled into a test tube 
graduated at 5 ml. and 7 ml. and containing 1 ml. 
of 4% aqueous Nat S03 solution. During distillation 
the tip of the condenser was immersed in the 
distillate. Distillation was stopped when the 
volume of liquid in the receiver was 5 ml. and 
after washing down the tip of the condenser the 
distillate was diluted to 7 ml. with water. Three ml. 
of this solution were transferred to a test tube, 
5 ml. of 0.2 chromotropic acid in 30N-H2 S01, 
added and the mixture heated in a boiling water 
bath for 30 min. After cooling to room temperatur 
the mixture was diluted to 10 ml. with 18N -H2SO4 
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},Lg. HCHO PER ALIQUOT. 
FIG.16. CALIBRATION CURVE FOR FORMALDEHYDE 
ESTIMATIONS . 
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measured in a 'Spekker' photoelectric absorptiomete 
using Ilford 605 filters, against a reagent 'blank' 
mixture. 
Calibration curve. 
A specimen calibration curve is shown in Fig.16. 
This was prepared from a standard solution of 
hexamethylene tetramine containing 16.3 4g. per ml. 
This is equivalent to 20.9 pg. formaldehyde per ml. 
Aliquots of this solution were used and the volume 
made up to 1 ml. with water. Stannous chloride and 
sulphuric acid were added and the procedure 
described above was followed. 
Values for the FSS determined are expressed as 
}gig. formaldehyde per 24 hr. measured after 
periodate oxidation rather than as mg. per 24 hr. 
of some hypothetical steroid. 
3. Properties of cold acid -labile FSS. 
Using method 1 the presence in normal male 
urine of FSS labile to cold acid in amounts varying 
between 8 µg. and 20 1'g. HCHO per 24 hr. was 
readily confirmed. When method 2 was evolved it 
as necessary to check these values. Method 2 was 
uch quicker than method 1 in that the second 
extraction/ 
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extraction of FSS, from aqueous ethanol, was 
dispensed with. Also the method should be more 
quantitative and accurate since the volume of 
chloroform used is much greater than that used in 
the second extraction in method 1. Values for 
cold acid labile FSS from 0 to 19.2 pg. HCHO per 
24 hr. were obtained. 
The time required for destruction of the cold 
acid -labile 733 was also determined. A washed and 
dried chloroform extract of urine was divided into 
equal parts and determinations of FSS were 
performed on each part after they had stood for 
varying intervals of time at pH 1 at roof 
temperature. The results recorded in Table 16 
confirmed that destruction of the FSS was complete ! 
in hr. to 1 hr. 
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Table 16. Time required for destruction of cold 
acid -labile FSS. 
pH l 








0.060 0.053 0.052 
0 45.0 52.5 51.0 
0.065 0.055 0.052 
0.047 0.040 0.040 
i 34.9 39.0 40.5 
0.048 0.040 0.042 
0.040 0.040 0.045 
1 31.5 38.2 42.0 
0.045 0.038 0.043 
0.040 0.043 0.042 
2 29.3 40.5 41.2 
- 0.039 0.042 
0.042 0.038 0.041 
3 29.3 39.0 39.7 
0.039 0.042 0.040 
1 
FSS in pig. HCHO per 24 hr. 
In all the experiments performed so far the 
chloroform extracts had been evaporated at less 
than 40 °C. Experiments were performed to determine 
whether the cold acid- labile FSS were also thermo- 
labile. 
urine/ 
Washed and dried chloroform extracts of 
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urine were divided into two equal parts and cold 
acid -labile FSS determined in each. The chloro- 
form of one half. was evaporated to dryness at a 
temperature of less than 40 °C.; the other 
chloroform extract was evaporated at 60 °C. or 
refluxed for one hour prior to evaporation. The 
results, recorded in Table 17, suggested that the 
cold acid -labile FSS was not thermolabile. 
Table 17. Thermostability of cold acid -labile FSS. 











Urine 1 34.1 12.8 34.1 12.8 
2g 36.0 0 32.4 0 
u 3 26.4 0 30.4 2.0 
is 4 21.2 0.8 17.6 0 
FSS in Pg. HCHO per 24 hr. 
Many of the experiments reported above were 
performed not on 24 hr. samples of urine but on 
combined 3 hr. collections of urine so that there 
would be less chance of any acid -labile material 
undergoing/ 
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undergoing change during collection of the urine. 
4. FSS present in solvents. 
Soon after the commencement of the work it 
was discovered that the ethanol and chloroform 
used in the experiments contained considerable 
amounts of FSS. The alcohol used had been 
purified by allowing it to stand over m-phenylene- 
diamine for several days and then distilling. 
Determinations by Mrs Atherden showed this ethanol 
to give rise to about 1 HCHO per ml. on 
periodate oxidation. Ethanol almost free of FSS 
could be obtained by the following procedure: 
(i) distil, (ii) oxidize for 1 hr. with periodic 
acid, (iii) decompose excess periodate with 
stannous chl ride, acidify and distil and (iv) 
allow distillate to stand over m- phenylenediamine 
for four days and redistil. Since the FSS in 
ethanol could not be entirely removed and since it 
appearet that it was also capable of being 
regenerated the use of ethanol was dispensed with 
in later experiments and glacial acetic acid 
utilized. The FSS in chloroform was more 
difficult to eliminate; a varying proportion of 
it/ 
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it was shown to be acid -labile but since the 
purification by acid treatment was time- consuuing 
and costly and only partially successful it becae 
necessary to do blank deter :ainations on the chloro- 
form used in each experiment. ?,Tarrian and 
Atherden (1953) found the FSS in chloroform to 
give 1.0-1.2 ;_g. HCHO per litre. More recent 
determinations have shown the value to vary between 
1 and 3 rg. HC30 per litre, so that for a 24 hr. 
collection of urine the FSS in the chloroform used 
in its extraction could account for bet.reen 6 and 
18 ;_'.g. HCHO per 24 hr. Using the above values for 
FSS in ethanol and chloroform it is possible to 
calculate the amount of FSS contributed by the 
solvents to the total FSS determined in an experi- 
ment of the type described by Paterson and °' arrían 
(1953b). Assuring a urine volume of 1500 ml., 
then as much as 30 pg. HCHO per 24 hr. could be 
obtained from FSS in the solvents use That 
large amounts of FSS were present in the solvents 
use is suggested by the report of Paterson (1953) 
that about 80_ of the FSS were found in the first 
chloroform extract o:C urine and about 15 in the 
second. These results have been confirme by 'rs 
Atherden/ 
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ßtherden and these experiments also showed that 
the FSS measured in the second CHC13 extract are 
no greater than the FSS found in an equivalent 
volume of chloroform treated in the same way. 
Thus approximately 30% of the FSS determined by 
Paterson must have come from the solvents used. 
Some of the FSS in chloroform were shown to 
f 
be acid -labile. Cold acid -labile FSS were 
determined in large volumes of chloroform (4 to 
6 litres) using method 1. The results are 
recorded in Table 18. 
Table 18. Determination of cold acid -labile FSS 
present in chloroform. 
Time stood 
at pH 1 





















FSS in the solvents were not affected by being 
refluxed for one hour. 
The/ 
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The discovery of so much SS in the solvents 
used and that fact that some of it was cold acid - 
labile raised doubts concerning the existence of 
cold acid -labile FSS in urine. Accordingly a 
series of urines were assayed for cold acid - 
labile FSS and with each determination a chloro- 
form blank was included. Although, at varying 
times, fourteen determinations of cold acid - 
labile PSS were made on normal male urines in 
only two cases were significant amounts (i.e. 
greater than 6 kg. HCHO per 24 hr.) found. For 
r=ost determinations method 2 was used; it has 
been shown that the ethanol used to dissolve the 
acid in chloroform contributed little, if any, 
FSS to the total. 
The opportunity arose of studying the urinary 
excretion of FS3 of a female patient on a salt - 
free diet. After a control period of ten days the 
patient was on the diet for twelve days. Cold 
acid- labile FSS were determined on twenty days 
using method 2. On only four days were significant 
amounts (more than 6 fig. HCHO per 24 hr.) of cold 
acid -labile FSS detected. 
5. / 
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5. Cold acid -labile FSS in the urine of normal 
males after injection of ACTH. 
If the cold acid -labile FSS was an artifact 
it would not be expected to increase after the 
injection of ACTH. Paterson and -!arrian (1953b) 
had found amounts of cold acid -labile FSS of 40 Pg. 
HCHO per 24 hr. in the urine of a patient with 
rheumatoid arthritis injected with ACTH. It was 
therefore essential to test the effect of ACTH on 
the excretion of F3S and two experiments were 
performed on normal males. After a three day 
control period 40 units of 'ACTH' gel were 
injected daily for two days and the determinations 
continued for a further three days. In the 
first experiment cold acid labile FSS were 
determined by both methods and chloroform 'blanks' 
were performed on each pool of chloroform used. 
Although after the injection of ACTH the 
excretion of unconjugated FSS increased four- 
fold only insignificant amounts (0 to 2.8 ég. 
HCHO per 24 hr.) of cold acid - labile FSS were 
detected. 
In the second experiment only _._..__ . 1 was 
used and on most days the effect of 57a :orating 
the/ 
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the chloroform extract at 60 °, or refluxing it 
for g- hr. before evaporating, was determined. The 
increase in FSS after the injection of ACTH was 
smaller than in the first experiment (100% in- 
crease) and again only insignificant amounts of 
cold acid -labile FSS (0 to 3.3 Pg. HCHO per 24 
hr.) were detected. 3vaporating at a higher 
temperature or refluxing did not affect the 
results. Thus the finding of Paterson and Marrian 
was not substantiatëd. 
6. Discussion. 
The occurrence of cold acid -labile FSS in 
urine has also been reported by Bayliss (1952) and 
yenning (1952b;Venning, Dyrenfurth and Karûin, 
1953). Yenning found that extraction of urine at 
pH 1 at frequent intervals over 24 hours gave a 
higher value than an extraction on acidification 
to pH 1 and another extraction 24 hours later 
using both chemical and bioassay. This does not 
necessarily mean that destruction due to acid was 
taking place; it could be that frequent removal 
of the hydrolysis products allows further hydrolysis 
to proceed and that this is inhibited if the 
products/ 
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products are not removed, or that frequent 
removal prevents destruction by other means, e.g. 
by microorganisms. More direct evidence for the 
presence of acid- labile material was obtained 
from an experiment in which two lots of urine 
were allowed to stand at pH 1 for 3 hr. and for 
24 hr. The urines were extracted first at pH 1 
and the sodium_ hydroxide washings were analysed. 
The results are shown in Table 19. 
Table 19. Effect of acid on recovery of corti- 
coids. Two lots of urine acidified to pH 1. 
Extracted 
at pH 6. 
A. Extracted 
after 3 hr. 
B. Extracted after 24 hr. 
FSS Bioassay PS FSS Bioassay 
Re- extracted 
at pH 1 0.367 0.033 





;uantites expresse;, in mg. of steroid per 
litre of urine. 
PS = substances giving a positive reaction in 
the test of Porter and Silber (1950); i.e. 






Although there was an increased amount of 
corticoid extractew at pH 6 when chemical pro- 
cedures were used there was a loss of activity 
judged by bioassay. These tvo experiments on 
whole urine are difficult to evaluate because the 
two processes of destruction and hydrolysis are 
taking place at the same time and urine may 
tain formaldehydogenic material which is not 
steroidal. The decrease in material found by 
bioassay would, if it were a formaldehydogenic 
steroid, correspond to about 1.5 pg. HCHO per 
litre of urine which is very much less than the 
amounts of labile material detected by Paterson 
and ?arrían. Also before it is assumed that the 
labile FSS, if present in urine, and the material 
detected by Venning are the same it must be shown 
that the destruction in yenning's experiments 
also occurs in 2 - 1 hr. after acidification. In 
the bioassay performed by Paterson (unpublished) 
using the liver glycogen test the activity of the 
chloroform extract of urine was increased by 
standing at pH 1 for 3 hr. It must also be shown 
that the decrease found by bioassay is accompanied 
con- 
by a decrease in FSS. 
bioassay/ 
The decrease in the 
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bioassay value could be due to a transformation 
of some part of the molecule other than the side 
chain. Yenning has also found conjugated corti- 
coids which are soluble in chloroform and which 
are removed by alkali washing. Some of these 
conjugated corticoids are labile at pH 3 as 
judged by bioassay. It is unlikely that this 
material is the same as the labile FSS detected 
by Paterson and Tarrian for in the experiments of 
the latter authors such material would have been 
removed by the washing procedure employed. The 
arount of labile corticoid found by Yenning 
(0.060 mg. per 24 hr.) represents about 5 ig. 
HCHO if forr,aldehydogenic. 
Bayliss (1952) has attempted to study the 
different types of conjugated FSS in urine and 
to devise a procedure that would give the maximal 
yield of hydrolysed FSS. He confirmed that with 
most urine specimens extraction immediately after 
acidification to pH 1 gave a higher yield of FSS 
than extraction at pH 7.4 but found no significant 
difference between FSS obtained from urine extracted 
at pH 1 and that obtained by first extracting at 
pH 7.4 followed by re- extraction at pH 1. It 
was/ 
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was shown that most of the FSS extracted from 
urine at pH 1 was acid- labile when stood at pH 1. 
at room temperature for 24 hr. but no experiments 
were performed to determine whether the des- 
truction was gradual or complete within one hour. 
Other experiments to determine the effect of 
prolonged standing in acid on the yield of FSS 
used whole urine. A gradual destruction occurred 
over 24 hr. (in contrast to the finding of 
Paterson, Cox and TTarrian,l95O) and in some cases 
the whole of the unconjugater fraction was 
destroyed. In these experiments little 
destruction occurred during the first four hours; 
most occurred between 4 hr. and 24 hr. after 
acidification. 
De Courcy and Gray (1953) have also studied 
the effect of acid on urinary FSS. They have 
shown that the amount of formaldehyde liberated 
when washed urinary extracts are dissolved in 
glacial acetic acid and oxidized is greater than 
when the extracts are dissolved in ethanol and 
oxidized under the same conditions. Paterson and 
':arrian (1953a) found that the same values for 
FSS were obtained for the sane extract with either 
solvent/ 
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solvent. Although de Courcy and Gray could 
obtain acid hydrolysis curves similar to those 
of Paterson, Cox and Marrian when using the 
method of Talbot, Saltzman, Wixon and Wolfe 
(1945) for measuring reducing steroids, no 
regular form of hydrolysis curve was obtained 
when the formaldehydogenic method was used. 
Frequently there was no change in the amounts of 
FSS determined at varying times of hydrolysis. 
Using paper chromatography and spray reagents 
which would detect steroids with a t4-3 keto 
group or an a -ketol group it was found that after 
urine had been extracted at neutral pH extracts 
prepared by extraction immediately after acidifi- 
cation to pH 1 or after standing at pH 1 for 24 
hr. rarely contained any detectable steroid 
material. When pregnancy urine was acidified to 
pH 1 and separate aliquots extracted after 0, 2, 
4 and 24 hr., paper chromatography showed that 
generally there was a certain amount of destruction 
of steroids after 24 hr. at pH 1. 
Heard, Sobel and Venning (1946) showed that 
if urine was acidified to pH 1 the amount of 
reducing substances that could be extracted was 
doubled but if the urine after acidification was 
neutralized/ 
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neutralized before extraction an increased amount 
of reducing substances was not obtained. The 
method used by these workers measures those com- 
pounds which will reduce phosphomolybdic acid. 
This acid is not only reduced by primary a -ketol 
groups, such as are found in the side - chains of 
the adrenocortical hormones, but also by secondary 
a -ketol groups and 0- unsaturated -3- ketosteroids 
and the reducing power of these groups is 
influenced by the presence of other functional 
groups in the steroid molecule. When a urine 
extract was allowed to stand in 2% sulphuric acid 
at room temperature for 1 hr. 60% of the reducing 
power was lost. When a solution of 11- deoxy- 
corticosterone was treated similarly 25% of the 
reducing power was lost and oxidation of the 
extract with periodic acid showed that the a- 
ketol side -chain had not been affected. Thus 
it is probable that the loss of reducing power 
of urine extracts on acidification was due not 
to destruction of the side -chain but to trans- 
formation of some other part of the molecule if 
the material destroyed was steroidal. 
While the presence in urine of FSS unstable 
at pH 1 at room temperature for 24 hr. seems well 
proved the presence of FSS. labile in one hour 
has/ 
-146- 
has not been shown by any of the above investi- 
gators. It is known that the formaldehydogenic 
properties of cortisol, cortisone, 1l- deoxy- 
corticosterone and 17- hydroxy -11- deoxycortico- 
sterone are unaltered on standing in aqueous 
solution at pH 1 at room temperature for 24 hr. 
and the present author has shown by visual 
estimation after paper chromatography that the 
above steroids are quantitatively recovered after 
standing at pH 1 for one hour. Although these 
solutions of pure steroids are stable under the 
above conditions it does not necessarily follow 
that the steroids will be as stable in urine. It 
was thought early in the investigations that the 
cold acid -labile FSS might be aldosterone or one 
of its metabolites. However, it has been shown 
by Simpson, Tait, Wettstein, Neher, von Euw, 
Schindler and Reichstein (1954) that 80% of 
aldosterone is recovered after standing for 
twenty hours in aqueous solution at pH 1. Also 
the amounts of cold acid -labile FSS detected by 
Paterson and Marrian greatly exceed the amount of 
aldosterone detected in urine. The latest and 
largest value for the aldosterone content of 
urine is 3.5 pg. per 24 hr. Luetscher and Axel - 
rad (1954) found the excretion of aldosterone to 
be/ 
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be increased above normal by restricting the 
sodium intake but the patient on a salt -free 
diet studied in the present work showed no 
definite increase in excretion of cold acid - 
labile FSS. 
Determination of small amounts of cold 
acid -labile FSS are within the limits of experi- 
mental error of the method used. With the 
aliquots of urine normally used in the determin- 
ations a difference in Spekker readings of 0.005 
between the 0 hr. and 1 hr. extracts would give a 
value for acid -labile FSS of 4 to 5.4 µg. HCHO 
per 24 hr. For this reason values of less than 
6.0 pg. HCHO per 24 hr. have been regarded as 
insignificant. Duplicate determinations of FSS 
may vary by a Spekker reading of 0.004. 
Paterson and Marrian found the values of 
cold acid -labile FSS to range from 8.4 to 27.4 4g. 
HCHO per 24 hr. Although it is possible to 
ascribe some of this to FSS in the solvents used 
it does not seem possible to account for all the 
labile FSS found by the above authors in this 
way. Nor can it explain the rise in labile FSS 
found by Paterson and Marrian after the injection 
of ACTH nor the few cases in the present work 
where/ 
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where relatively large amounts (greater than 6 pg. 
HCHO per 24 hr.) of labile FSS were detected. It 
is certain that if cold acid -labile FSS do exist 
in urine they are present in much smaller 
quantities than suggested by the work of Paterson 
and Marrian. Taking the above facts into account 
it was thought that a continuation of the work 
at this time would not be profitable. 
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PART III. THE ATTEMPTED ISOLATION OF TETRA - 
HYDROCORTISONE GLUCURONOSIDE FROM 
NORMAL MALE URINE. 
-150- 
1. Introduction. 
Tetrahydrocortisone (3a:17ä:21- trihydroxy_5P- 
pre gnane- 11:20- dione) was first isolated from 
normal human urine by Schneider (1950e) who 
- obtained 6 mg. as the diacetate from 1000 litres 
of unhydrolysed urine. It was subsequently 
isolated from normal urine by Baggett, Kinsella 
and Doisy (1953) and from the urine of patients 
treated with ACTH or cortisone by Lieberman, 
Katzenellenbogen, Schneider, Studer and Dobriner 
(1953). These two groups of workers and also 
Schneider (1952) obtained the compound after the 
urine had been hydrolysed with f- glucuronidase 
preparations and it appeared that most of the 
tetrahydrocortisone was present in a conjugated 
form, most probably as the glucuronoside. 
Determinations by Baggett et al. of the daily 
excretion of tetrahydrocortisone showed that this 
varied from 2.0 to 7.4. mg. so that the amount of 
tetrahydrocortisone glucuronoside present in 
urine would be about 3 to 11 mg. per day. Thus 
it was considered that the isolation of the 
conjugate from normal human urine should be a 
feasible proposition. 
A procedure which it appeared might allow 
the/ 
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the conjugate to be isolated was worked out but 
before it could be applied to a large scale 
attempt the isolation of tetrahydrocortisone 
glucuronoside from the urine of a man fed 2 g. 
of tetrahydrocortisone was reported by Schneider, 
Lewbart, Levitan and Lieberman (1955). In view 
of this the problem was not pursued further. This 
part of the thesis describes briefly procedures, 
not recorded in chronological order, that were 
tried in the attempt to isolate the conjugate. 
2. Methods. 
Extraction of urine. 
Urine, and other aqueous solutions to be 
extracted with butanol unless otherwise stated, 
were acidified with dilute sulphuric acid to pH 1 
(pH checked using a glass electrode pH meter), 
saturated with sodium chloride and extracted 
three times with 1/4 vol. of butanol. Any 
emulsions that formed were broken by centrifugation. 
The butanol extracts were washed with 1 /10 vol. of 
water, neutralized with methanolic sodium hydroxide 
and the butanol removed in vacuo using an air leak 
and a water bath temperature of about 60 °C. 
Estimation/ 
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Estimation of tetrahydrocortisone glucuronoside. 
Since methods of estimating the conjugate 
directly were unsatisfactory the rather laborious 
procedure of hydrolysing the conjugate with an 
enzyme preparation, extracting the free tetra - 
hydrocortisone and estimating this after paper 
chro- natography was adopted. 
The residue of the fractions to be analysed 
was dissolved in water and an aliquot estimated 
to contain about 50 jig. of the conjugate was 
removed. The volume was made up to 8 by the 
addition of water, the pH of the solution adjusted 
to 4.7 and 2 rn.l. of M acetate buffer pH 4.7 and 
10 mg. of the soluble enzyme preparation described 
below added. The u?ixture was incubated at 37 °C. 
overnight and the next morning extracted twice 
with 2 vol. of chloroform. The chloroform 
extract was washed twice with 1/5 vol. of 0.1 N1- 
sodium hydroxide solution, twice with 1/5 vol. of 
distilled water, dried over anhydrous sodium 
sulphate and evaporated to dryness in vacuo. The 
residue obtained was dissolved in a small amount 
of methanol and applied to `7hatman No.42 filter 
paper for chromatography using the solvent mixture 
toluene:ethyl acetatenethanol;:Irater (05.1.5;60;40), 
a/ 
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a modification of system. C of Bush (1952). The 
papergrams were sprayed with alkaline blue tetra - 
zolium solution and the amount of tetrahydro- 
cortisone present estimated visually. 
The Rt, value of tetrahydrocortisone in 
this system was 0.20. A blue tetrazolium 
reducing spot with an RF value of 0.60 was also 
present on the papergrams, the amount of this 
substance present being about half that of tetra- 
hydrocortisone. This substance, if a steroid, 
was also present in a conjugated form and liberate 
by the enzyme preparation used. Whilst it behaved 
like tetrahydrocortisone glucuronoside in the 
extraction procedures it could be separated from 
the tetrahydrocortisone conjugate by the counter- 
current distribution and partition chromatography 
procedures described below. If this less polar 
substance is a steroid it may not have a hydroxyl 
group at position 17 since Dr Forsius (personal 
communication) who has been studying steroid 
conjugates in the urine of a person receiving 
cortisone has not detected a conjugate less polar 
than that of tetrahydrocortisone. Dr Forsius 
has used the method of Porter and Silber (1950) 
which/ 
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which is claimed to be specific for those steroids 
with a dihydroxyacetone side -chain for estimating 
the conjugated metabolites of cortisone so that 
his inability to detect this compound less polar 
than tetrahydrocortisone may indicate that this 
compound does not have a hydroxyl group at 
position 17. 
Preparation of concentrates of the enzyme 
p- glucuronidase. 
Dodgson, Lewis and Spencer (1953) have 
shown that certain marine molluscs are a rich 
source of p- glucuronidase and the procedure 
devised by Dodgson and Spencer (1953) for the 
preparation of concentrates of this enzyme has 
been followed. 
Limpets (Patella vulrrata) were collected 
locally from the sea shore. They were removed 
from their shells and the visceral humps cut off. 
The pooled viscera (about 200 g.) were macerated 
in about 1 litre of acetone (previously chilled) 
for 30 -60 sec. and then quickly filtered by 
suction. The debris was again macerated with 
500 ml. of acetone, filtered and well washed with 
cooled; 
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cooled acetone. The debris was sucked free 
from liquid and dried in vacuo.to give a light 
grey powder. 
This powder was then suspended in ten 
times its weight of water and the mixture well 
stirred. The suspension was centrifuged and the 
supernatants filtered through glass wool. The 
sedimented debris was resuspended in six times 
its weight of water and the process repeated. To 
the combined supernatants 8 vol. of cooled acetone 
were added to precipitate the protein. The main 
bulk of this supernatant was decanted, the 
remainder filtered and the residue, while still 
wet was well washed with acetone and finally dried 
in vacuo. The resulting water soluble white 
powder was used as the enzyme preparation. 
Determination of the activity of the enzyme 
preparation. 
The method described by Fishman, Springer 
and Brunetti (1948) has been used. A solution of 
the enzyme was made by dissolving 2 mg. of the 
powder in 10 ml. of water. The enzyme solution 
(0.1 ml.), acetate buffer 0.1 1:1, pH 4.7 (0.8 ml.) 
and 0.01 r:M solution of phenolphthalein glucuronid 
adjusted/ 
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adjusted to pH 4.7 (0.1 ml.) were mixed and 
incubated for 1 hr. in a water bath at 37 °C. The 
reaction was stopped by the addition of 1 ml. of 
5% trichloracetic acid and 2.5 ml. of buffer 
(pH 10.4 prepared by dissolving 32.6 g. of 
glycine, 25.3 g. of sodium chloride and 15.5 g. 
of sodiurl hydroxide in 2 litres of water) and 
1.5 ml. of water added. The resulting solution 
was read at wavelength 540 mµ against a reagent 
blank and the amount of phenolphthalein released 
calculated from a calibration curve. Usually 
1 g. of the water soluble powder had an activity 
of about 1,500,000 units. (1 unit is defined as 
the P g. of phenolphthalein liberated in 1 hr. by 
1 g. of the enzyme preparation). 
3. Purification of the conjugate by extraction 
procedures. 
It was decided to try first some of the 
extraction procedures that had proved successful 
in the isolation of oestriol glucuronoside from 
urine (Cohen and Harrian, 1936; Cohen, Marrian 
and Odell, 1936). 
Extraction/ 
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Extraction of the conjugate from urine by butanol. 
A sample of urine (150 ml.) was divided 
into three equal parts. One was hydrolysed 
enzymically, the second extracted with butanol 
at neutral pH and the third extracted after 
acidification to pH 1 with sulphuric acid. The 
residues obtained from the butanol extracts were 
dissolved in 50 ml. of water and hydrolysed 
enzymically. The results showed that the 
conjugate of tetrahydrocortisone, like that of 
oestriol, was extracted by butanol from urine 
acidified to pH 1 but not from unacidified urine. 
Extraction of the conjugate from butanol by 
aqueous alkali. 
A butanol extract of urine was divided into 
two equal parts. One part was evaporated to 
dryness and the residue hydrolysed by enzyme. The 
other half was neutralized and extracted twice 
with 1/2 vol. of 5% (w /v) sodium bicarbonate 
solution.' The butanol was next extracted twice 
with 1/2 vol. 0.3 N- sodium hydroxide solution. 
These alkali extracts were neutralized and 
hydrolysed by enzyme. Finally the butanol 
remaining from the alkali extractions was 
evaporated/ 
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evaporated to dryness and the residue hydrolysed. 
The results showed that the bicarbonate had 
extracted about 75% of the conjugate. The sodium 
hydroxide had extracted the remaining 25 and 
none was left in the butanol. Oestriol 
glucuronoside is also extracted from butanol by 
0.8% sodium carbonate solution and by sodium 
hydroxide solution (Cohen and Marrian, 1936; 
Cohen et al., 1936). 
In another experiment it was shown that by 
acidification of the alkali extracts the conjugatf 
could be extracted with butanol and from the 
amount of residue obtained by evaporation of the 
butanol it was obvious that a high degree of 
purification had been obtained. Only a small 
amount (about 15 %) of the conjugate was extracted 
by butanol from the alkaline phase before 
acidification. 
Distribution between quinoline and aqueous alkalis. 
Cohen and Marrian (1936) had found that 
oestriol glucuronoside could be extracted from 
acidified aqueous solutions by quinoline. Washing 
the quinoline solution with sodium carbonate 
solution removed much piented material but only 
traces of the conjugate. Most of the conjugate 
could/ 
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could be recovered by extracting with sodium 
hydroxide. A similar procedure was tried with 
the conjugate of tetrahydrocortisone. 
An aliquot of an aqueous solution of the 
residue from a butanol extract of urine was 
hydrolysed enzymically. The remainder of the 
solution was acidified to pH 1 and extracted twice 
with 1/2 vol. of quinoline. The quinoline 
extract was then successively extracted twice 
with 2 vol. of 5% sodium bicarbonate solution, 
twice with 2 vol. of 10/ sodium carbonate solution 
and twice with 2 vol. of 0.1 N- sodium hydroxide 
solution. Aliquots of the alkali solutions and 
of the quinoline extracted aqueous phase were 
then hydrolysed. The results showed that while 
quinoline effectively removed the conjugate from 
an acidified aqueous solution, sodium bicarbonate 
would extract only about 50% of the conjugate 
from the quinoline phase and this bicarbonate 
extract was highly pigmented. A further amount 
of the conjugate (10 -25 %) was recovered in the 
sodium hydroxide fraction. 
Extraction of an aqueous solution of the 
conjugate at pH 7.4 with quinoline removed only a 
small amount of pigment and none of the conjugate. 
Thus/ 
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Thus the quinoline procedure was of no use in the 
purification of tetrahydrocortisone glucuronoside. 
Extraction of tetrahydrocortisone glucuronoside 
from aqueous solutions by ether, chloroform and 
ethyl acetate. 
Lieberman and Ilobriner (1948) have reported 
that when sodium pregnanediol glucuronosidate is 
dissolved in aqueous acid solution (pH 1) and 
continuously extracted with ether the unhydrolysed 
conjugate is obtained in the ether extract. When 
an aqueous acid (pH 1) solution of a residue 
obtained from a butanol extract of urine was 
continuously extracted with ether for seven hours 
it was shown that none of the tetrahydrocortisone 
glucuronoside had entered the ether phase and the 
conjugate was recovered from the aqueous phase. 
It was also shown that the conjugate could 
not be extracted from aqueous solution by chloro- 
form. 
When an aqueous solution of the conjugate 
was acidified to pH 1 and extracted twice with 
1 vol. of ethyl acetate the conjugate was 
approximately equally distributed between the two 
phases. None of the conjugate and little pigment 
were extracted by ethyl acetate from an aqueous 
solution at neutral pH. 
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Butanol has been the most widely used solvent 
for the extraction of steroid conjugates from urine. 
The effect of pH on the distribution of the con- 
jugated 17- ketosteroids between urine and butanol 
was studied by Bitman and Cohen (1951). At a pH 
less than 3 all the conjugated 17- ketosteroids 
were extracted but at higher pH values considerable 
amounts of the conjugates were not extracted. A 
similar finding has been reported by Crepy, Garrone 
and Jayle (1952) and these workers have used the 
method of fractionating the conjugates by extracting 
urine at different pH values with butanol to 
determine the excretion of different groups of 
steroids. Anderson and Warren (1951) have 
studied the extraction of conjugated androgens 
from acidified urine by different solvents. Using 
1/20 vol. of each solvent they found that n-butanol 
extracted 88% of the conjugate, iso- and sec - 
'Butanol 58% and tert -amyl alcohol 65. Ether, 
chloroform and ethylene dichloride removed 11, 8 
and 5% respectively, while toluene removed a 
negligible amount. Brooksbank and Haslewood (1950) 
found that 3a- hydroxy- 5a- androst- 16 -ene glucuronoside 
was appreciably soluble in chloroform. 
Edwards/ 
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Edwards, Kellie and Wade (1953) have shown 
that steroid conjugates can be quantitatively 
extracted from urine to which ammonium sulphate 
has been added by ether -ethanol mixtures. Butanol 
was equally effective while ethyl acetate removed 
80 of the 17- ketosteroid conjugates and ether 
only 24¡x. Fishman and Sie (1956) have used 
ethyl acetate to extract testosterone glucuronosid 
synthesized in vitro by liver slices of various 
animals, from an acidified aqueous solution. Thus 
while butanol or ether- ethanol mixtures appear to 
be the best solvents for extracting the conjugates 
from urine purification of the conjugates could 
perhaps be achieved by using extraction with various 
solvents at later stages in the purification 
procedure. 
4. Purification of the conjugate by counter- 
current distribution. 
The theory of counter - current distribution 
has been reviewed by Craig and Craig (1950). In 
the work described below separating funnels have 
been employed for they allow large volumes of each 
phase to be used. Due to the laboriousness of 
the/ 
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the procedure only a small number of transfers 
have been applied to the mixture containing the 
conjugate with the intention of removing the main 
bulk of impurities present. It was thought that 
this could best be achieved by finding a solvent 
system in which the conjugate had a partition 
coefficient of 1.0 so that the peak of the concen- 
tration of the conjugate would be at the centre of 
the distribution and the impurities present mainly 
at each end. 
Distribution using the solvent mixture butanol: 
0.5 M acetate buffer pH 4.7. 
Bitman and Cohen (1951) have reported that 
steroid glucuronosides have a pK value between 3 
and 4.5. Thus it was expected that the conjugate, 
of tetrahydrocortisone would be eoually distributed 
between butanol and an aqueous solution of about 
pH 4.5. When an extract of urine containing the 
conjugate was subjected to a 5 funnel distribution 
using the above system it was found that most of 
the conjugate was in funnel 3 with smaller amounts 
in funnels 2 and 4. Funnels 1 and 5 although they 
contained little conjugate contained much pigment 
and other material so that a considerable degree 
of/ 
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of purification of the conjugate had been 
achieved. 
The volume of each phase used in the 
distribution varied with the amount of material 
to be distributed and the procedures that had 
already been applied in its purification. Phase 
volumes of 100 ml. to 1 litre have been used. At 
the end of the distribution the aqueous phases 
were run off, adjusted to pH 1, extracted with 
the butanol phase and then extracted again with 
1/2 vol. of butanol. 
Although much purification was achieved by 
use this system it had the disadvantage that 
the butanol tended to remove acetic acid from the 
lower phase so that there was a gradual change in 
pH as the distribution proceeded. 
Distribution using the solvent mixture ethyl 
acetate:dilute sulphuric acid pH 1.5. 
It was found that tetrahydrocortisone 
glucuronoside also had a partition coefficient 
of about 1.0 in the above system. At the end of 
the distribution the ethyl acetate was removed 
and evaporated to dryness and the aqueous phase 
in each funnel extracted twice with 1/2 vol. of 
butanol. The residue obtained by evaporation of 
the/ 
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the butanol from each funnel was combined with the 
corresponding residue obtained from evaporation 
of the ethyl acetate. It was shown in another 
experiment that no loss of conjugate occurred 
during evaporation of the ethyl acetate. 
This system appeared to have a lower 
capacity than the butanol:acetate buffer system 
but was very useful in the purification of 
concentrates of the conjugate. 
Counter -current distribution has been used 
by Schneider et al. (1955) for the isolation of 
tetrahydrocortisone conjugate from urine; the 
solvent mixture ethyl acetatesbutanol :0.01 N- 
hydrochloric acid was used. More recently 
Lewbart and Schneider (1956) have employed counter 
current distribution using the solvent mixture 
ethyl acetate :n hexane :l' acetic acid to isolate 
androsterone glucuronoside from urine. The only 
other reported application of counter-current 
distribution for the separation of steroid 
conjugates is that of Saier, Grauer and Strickler 
(1956). Using fifty transfers no separation of 
the sodium 3a :20a- dihydroxy -5ß- pregnane 
glucuronosidate/ 
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glucuronosidate complex was obtained with the 
system butanol:0.1 N- sodium hydroxide solution. 
5. Purification of the conjugate by adsorption 
chromatography. 
The theory of adsorption chromatography 
has been reviewed by Cassidy (1951). It was 
anticipated that the most commonly used adsorbent, 
alumina, would be of little use since it is known 
that the free corticoids are strongly adsorbed 
and tend to be destroyed. Brooksbank and 
Haslewood (1950) found that after chromatography 
of sodium pregnanediol glucuronosidate on an 
alumina column only 20% was recovered. The 
recovery of their 'pregnanediol -like glucuron- 
osidate' after chromatography was about 80% but 
no clear cut separation was achieved. Alumina 
has also been used by West, Reich and Samuels 
(1951), again with little success. Ethanol - 
acetic acid mixtures were needed to elute the 
conjugates and a mixture of the conjugates of 
androsterone and etiocholanolone was not 
resolved. 
The following adsorbents were tested: - 
Deactivated/ 
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Deactivated magnesium silicate- Celite. 
A 1:1 mixture of magnesium silicate, 
deactivated by exposure to the atmosphere, and 
Celite was used. The partially purified extract 
of urine was dissolved in 1 ml. of ethyl acetate 
and applied to the column. The conjugate was 
not eluted by ethyl acetate or ethanol. 
Celite. 
A slurry of Celite in ethyl acetate was 
made and poured into a column. The column was 
packed under pressure and the partially purified 
extract of urine dissolved in 1 ml. of ethyl 
acetate and applied to the column. The conjugate 
appeared in the first 10 ml. of eluate. 
Starch. 
This was dried by heating overnight at 
80 °C. and a column prepared in ethyl acetate. The 
conjugate appeared in the first 20 ml. of eluate 
so that little or no adsorption had taken place. 
None of the three adsorbents tested was of 
use in the purification of the conjugate for the 
conjugate/ 
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conjugate was either so strongly adsorbed that it 
could not be eluted or, if adsorbed, the adsorptio 
was so weak that the conjugate was eluted with the 
main band of pigment and impurities. A separation 
of the methylated and acetylated glucuronosides of 
17- oxosteroids on alumina has been reported by 
Kellie and Jade (1956) . 
6. Purification of the conjugate by partition 
chromatography. 
It was considered that partition chromato- 
graphy would be more suitable than adsorption 
chromatography since, due to the milder conditions, 
there would be less chance of destruction taking 
place and the resolution obtained is greater. The 
equation derived by Martin and Synge (1941) has 
been modified by Butt, Morris, Morris and 
Williams (1951) and expressed as :- 
K = Vr 
LAs 
- AL _ 
partition coefficient 
conc. in statkonar phase 
where K = the P conc. in mobile phase 
Vr = retention volume i.e. vol. of eluate to 
peak conc. of solute 
L = length of column 
AL = cross -sectional area of mobile phase and 
As = sr s! stationary phase 
By/ 
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By rearranging this equation: - 
Vr = K L As + LAL 
and thus under ideal conditions and for similar 
columns the retention volume of a solute depends 
only on its partition coefficient. Since for the 
best resolution the solute should not leave the 
column too early it is obvious that the solute 
should favour the stationary phase i.e. increasin 
K increases Vr. In practice values of K from 
about 10 to 20 are best for if K is too large 
the resolution tends to become blurred due to 
diffusion taking place between the 'plates' of 
the column. 
The following systems have been 
investigated: - 
0.1 N- Sodium hydroxide solution:butanol. 
Whilst tetrahydrocortisone glucuronoside 
was readily extracted with butanol from acidified 
urine little was extracted at neutral pH. The 
preference of the salt form of the conjugate for 
the aqueous phase suggested that this solvent 
system would probably be suitable for 
chromatography of the conjugate. 
Celite/ 
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Celite was used as supporting medium and 
the method of packing the columns has been 
described by Bauld (1955). Eight ml. of sodium 
hydroxide were used per 10 g. of Celite and the 
extract containing the conjugate was applied to 
the column by dissolving it in a small volume of 
stationary phase, stirring in the requisite amount 
of Celite and packing this Celite onto the top of 
the column. The fractions of the eluate were 
neutralized and evaporated to dryness in vacuo. 
Using this system the conjugate of tetrahydro - 
cortisone usually appeared in the third and fourth 
fractions. 
However this solvent system had certain 
disadvantages. One was that stationary phase 
tended to be lost from the column with the result 
that the conjugate appeared in the eluate more 
quickly than was desired. No experiments were 
performed in which the proportion of stationary 
phase to Celite was varied. The amount used 
should not have been excessive and the slurry 
obtained on adding mobile phase to the Celite was 
the flocculent type recommended by Bauld. Dr 
Forsius (personal communication) has also found 
this solvent system to behave in a similar manner. 
Secondly/ 
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Secondly it is known that steroids with an a- 
ketol group are unstable in alkaline solution 
so that the eluate had to be neutralized as soon 
as it was collected. 
Citrate - phosphate buffer pH 2.5:ethyl acetate. 
It was known that ethyl acetate would not 
extract the conjugate from a neutral aqueous 
solution although it would from an acidified 
(pH 1) solution. Thus it should be possible to 
find a buffer solution of suitable pH value which 
could be used for the stationary phase. A citrat 
phosphate buffer (Mcllvaine, 1221) was found to 
be the most suitable and a pH of 2.5 to 2.7 
appeared to be the optimum value. Employing this 
system the first 20 ml. of eluate were always 
highly pigmented. The next 20 ml. of eluate 
were almost free of pigment and contained the 
conjugate. This system was most successful and 
the retention volume of the conjugate could be 
varied by varying the pH of the buffer. 
Water:butanol. 
For this solvent system starch was used as 
the support. The starch was made into a slurry 
with water - saturated butanol and poured into the 
column/ 
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column.. Since the flow rate was extremely slow 
in later experiments a mixture of equal amounts 
of starch and Celite was used. The system was 
unsatisfactory for contact between the water - 
saturated butanol and starch caused a decrease in 
pH of the system with the result that the conjuga 
was eluted together with the pigment in the ex- 
tracts and appeared in the first fraction of the 
eluate. Using a mixture of starch and sodium 
bicarbonate as the supporting medium or using a 
phosphate buffer of pH 7 as stationary phase 
instead of water did not lead to any improvement. 
Stein and Moore (1948) have studied the character 
istics of starch columns and have shown that the 
starch needs to be treated with 8- hydroxy- 
quinoline to remove traces of metal ions. The 
source of the starch was most important and 
potato starch was by far the most satisfactory. 
Other disadvantages were that the columns had a 
low capacity and that the eluate was contaminated 
with traces of carbohydrate. 
Sutherland and Marrian (1947) using a 
column of potato starch in moist butanol obtained 




glucuronosidate' mixture into ketonic and non - 
ketonic fractions and ",pest, Reich and Samuels 
(1951) used a similar column for the separation 
of the conjugates of testosterone metabolites 
but with no success. Edwards and Nellie (1956) 
have successfully separated the 17 ketosteroid 
conjugates present in the urine of a patient 
injected with testosterone by chromatography of 
the ketonic fraction of the urine extract on 
silica gel using 0.1 N- sodium acetate solution as 
stationary phase and chloroform containing 
ethanol and varying amounts of acetic acid as the 
mobile phase. Enzymic hydrolysis of the major 
peaks from the column showed the presence of 
androsterone, etiocholanolone and their 11p- 
hydroxy derivatives and also testosterone. This 
is the first demonstration in vivo of the con- 
jugation of a C -19 steroid in a position other 
than C -3. Fishman and Sie (1956) have shown in 
vitro that testosterone is conjugated with 
glucuronic acid by liver slices from various 
animals. It should be pointed out that silica gel 
columns are not true partition columns for a 
considerable degree of adsorption takes place. 
This 
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This may not always be advantageous. The only 
other report on the application of partition 






that of Anderson and Thrren (1951). 
tried reversed phase chromatography 
as stationary phase supported 
treated with dichlorodimethylsilane. 





When the work described in this part of 
the thesis was commenced no report on the success- 
ful application of partition chromatography to the 
separation of steroid conjugates had appeared. 
7. Discussion. 
Few steroid glucuronosides have so far 
been isolated from urine. Of those that have only 
four have been obtained in a pure or nearly pure 
state. The first to be isolated was oestriol 
glucuronoside (Cohen and I:arrian, 1936; Cohen et 
al., 1936). A butanol extract of pregnancy urine 
was extracted with sodium hydroxide solution. 
After acidification this solution was re- extracted 
with butanol and the residue from evaporation of 
the butanol subjected to the quinoline procedure. 
The/ 
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The purified oestriol glucuronoside was 
crystallized as the sodium salt from methanol. 
Venning and Browne (1936) isolated a glucuronoside 
of 53- pregnane- 3a :20a -diol also from pregnancy 
urine. The residue from a butanol extract of 
urine was dissolved in alkali and re- extracted 
with butanol. The residue from this butanol 
extract was dissolved in water and the conjugate 
precipitated by the addition of acetone. In 
1946 Marrian and Gough showed that 'sodium 
pregnanediol glucuronosidate' prepared by the 
method of Yenning and Browne contained about 
20¡ of a conjugate of 3a-hydroxy-5p- pregnan -20- 
one and Sutherland and Marrian (1947), by subject 
ing the conjugate mixture to a modified Girard 
separation, were able to isolate pregnanediol 
glucuronoside in an almost pure state. From the 
ketonic fraction they obtained the glucuronoside 
of 3a hydroxy -5p>- pregnan -20 -one which was about 
85 pure. 
No other steroid glucuronoside was isolate 
in a pure state until 1955 when Schneider et al. 
isolated the glucuronoside of tetrahydrocortisone 
from the urine of a man who had received 2 g. of 
tetrahydrocortisone over a period of four hours. 
The/ 
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The urine was collected for 16 hr., extracted at 
pH 1 with butanol and evaporation of the butanol 
left a residue which contained 50' of the steroid 
conjugate. This residue was distributed in a 
counter- current u achine using the system ethyl 
acetate:butano1 :0.01 N- hydrochloric acid (9 :1 :10) 
and pure tetrahydrocortisone glucuronoside was 
obtained although it was not crystallized. The 
solvent mixture used is similar to one (ethyl 
acetate :sulphuric acid pH 1.5) used in the present 
work. 
Recently Lewbart and Schneider (1956) have 
isolated androsterone glucuronoside from the urine 
of a man treated with dehydroepiandrosterone. The 
residue from a butanol extract of the urine was 
dissolved in 1% aqueous acetic acid and this 
solution was repeatedly extracted with ethyl acetate. 
The residue obtained from evaporation of the ethyl 
acetate was distributed in a counter- current 
apparatus using the solvent mixture ethyl acetate: 
n- hexane:l aqueous acetic acid (6:3:9) and 
crystalline androsterone glucuronoside was 
obtained. 
A number of steroid glucuronosides have 
been isolated in a semi -pure state. The conjugate 
of 
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of 3a:17a- dihydroxy- 5p- pregnan -20 -one was 
isolated by the method of Yenning and Browne 
from the urine of a female pseudohermaphrodite 
(Strickler, Shaffer, Wilson and Strickler, 1943; 
Yason and Strickler, 1947). Brooksbank and 
Haslewood (1950) isolated 3a-hydroxy-5(3- androst- 
16 -ene glucuronoside by extracting normal male 
urine with butanol at neutral pH, entrainment 
of the residue from the butanol on barium 
phosphate and chromatography on alumina. The 
final product contained 5p- pregnane- 3a:20a -diol 
in addition to other unidentified material. By 
treating the urine from a female pseudohermaphro - 
dite according to the Yenning and Brown method 
Mason and Kepler (1945b) isolated a crystalline 
fraction whose melting point was not raised by 
repeated crystallization. However hydrolysis 
showed that this crystalline material was a 
mixture of conjugates and from the hydrolysate 
5ç- pregnane- 3a :20a -diol, 3a:17a:20a-trihydroxy- 
5p- pregnane and at least four ketonic compounds 
were isolated. West, Reich and Samuels (1951), 
again using the Yenning and Brown method with 
the urine from a man receiving testosterone, 
obtained/ 
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obtained a product which behaved as a single 
substance on chromatography on paper and alumina 
but which yielded a mixture of androsterone and 
etiocholanolone on enzymic hydrolysis. Tetra - 
hydrocortisone glucuronoside was not precipitated 
from aqueous solution by the addition of acetone. 
Thus it is seen that the first isolation of 
a conjugate in every case except one has been from 
urine in which there was an amount of the conjugate 
greatly in excess of that found in normal urine. 
It has been shown that many other steroids are 
probably also excreted as glucuronosides (Lieberman 
and Dobriner, 1948; Romanoff, Wolf, Constandse 
and Pincus, 1953). Only in the case of the 
oestriol conjugate has it been shown by isolation 
that the acid is glucuronic acid (Grant and 
Marrian, 1950) but in the case of the conjugates 
of pregnanediol and tetrahydrocortisone the 
isolated conjugate or a derivative has been shown 
to be identical with the same compound synthesized 
from the steroid and glucuronic acid. 
A number of solvent mixtures suitable for th 
separation of steroid sulphates and glucuronosides 
by paper chromatography have recently been describe 
by Lewbart and Schneider (1955) but have not yet 




West et al. (1951) had separated the sulphates of 
androsterone and dehydroepiandrosterone by paper 
chromatography in the butanol:water system a 
separation of the glucuronosides of androsterone 
and etiocholanolone was not achieved. 
The discovery of methods for purifying and 
isolating the conjugates is important for devising 
methods for the quantitative estimation of steroids 
especially those originating in the adrenal cortex, 
in urine. It is known that many steroids are 
transformed during hydrolysis with acid and 
enzymic hydrolysis is also unsatisfactory for a 
method which is to be used routinely. Not only 
does the enzymic hydrolysis greatly lengthen the 
time required to perform an estimation but when 
applied to urine hydrolysis is possibly not complet 
and variable since competitive inhibition may occur 
due to the presence of non -steroid glucuronosides 
in urine and in addition urine may also contain 
other substances that inhibit the activity of the 
enzyme. Some of the difficulties encountered in 
quantitatively determining urinary corticosteroids 
have been discussed by Marrian (1951). It would 
appear that the best method of estimating urinary 
steroids would be to estimate the conjugates so 
that hydrolysis procedures are avoided. Although 
the/ 
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the extraction of the conjugates may not be 
quantitative it is known that the extraction of 
the highly oxygenated corticosteroids from urine 
by the usual extraction procedures is not 
quantitative either (Baggett et al., 1953; 
Fukushima et al., 1955; Nadel et al., 1956). In 
addition to the usual extraction procedures it 
should be possible to separate the conjugates by 
use of a counter- current distribution apparatus of 
the type described by Craig, Hausmann, Ahrens and 
Harfenist (1951) although this is unlikely to 
become a routine procedure. Another possible 
method would be the use of ion- exchange resins. 
Only one report has appeared concerning the use of 
these resins for the concentration of urinary 
conjugates (Anderson and Warren, 1951) and in 
this case the trials were unsuccessful. 
Thus although the primary aim when the work 
described here was commenced has not been attained 
much has been learnt of the properties of tetra - 
hydrocortisone glucuronoside,the most abundant 
urinary corticosteroid conjugate, and this 
information may be of use in the elaboration of 
methods for the estimation of urinary cortico- 
steroids. 
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APPENDIX I. THE ISOLATION OF FURTHER 
CRYSTALLINE COMPOUNDS FROM EXTRACTS 
OF NORMAL NiA.LE URINE. 
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As can be seen from Table 14 (Appendix 2) 
only two steroids containing the 5- en -3ç -ol group 
have been isolated from the urine of normal people 
The residues of the urine extracts from which K2 
had been isolated had been stored and therefore 
provided ideal starting material for investigating 
the presence in normal urine of compounds contain- 
ing the 5- en -3f -o1 group. 
The urine residues were subjected to the 
Girard separation outlined in Fig. 3 (Part I) with 
the modification that ether instead of chloroform 
was used to extract the non ketonic and ketonic 
fractions so that caffeine which appears in the 
non - ketonic fraction when chloroform is used 
would not be extracted. The weights of the 
fractions were : - 
Ikon- ketonic 1.5125 g. 
Ketonic 0.9133 g. 
These fractions were then distributed in a 100 
tube all -glass counter- current apparatus of the 
type described by Craig et al. (1951). The 
partition coefficients for a few neutral steroids 
in various solvent mixtures composed of ethyl 
acetate, cyclohexane, ethanol and water have been 
determined by Engel, Alexander, Carter, Elliott 
and/ 
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and ebster (1954) and the above solvent mixture 
has been used in the present study. Unfortunately 
the partition coefficient of only one steroid with 
a 5- en- 3(3 -ol group, namely dehydroepiandrosterone, 
in this system was known. The two phases of the 
system were mutually saturated before use and the 
distributions were performed in a constant temper - 
ature room maintained at 25 °C. An upper and lower 
phase volume of 40 ml. per tube has been used in 
both experiments. 
Distribution of the non ketonic fraction. 
For this distribution the solvent mixture 
ethanol :water:cyclohexane; ethyl acetate 8 :2 :8 :2 
was employed. In this system the partition 
coefficient of dehydroeolandrosterone is 0.21. 
The non ketonic fraction was dissolved in 40 ral. 
of lower phase and placed in tube 0 of the machine 
After completion of the fundamental procedure the 
upper phase was recycled for 300 cycles. The 
distribution pattern was then determined by 
removing 0.2 ml. of each phase from each tube and 
subjecting these to the Pettenkofer reaction 
described in Part I. The distribution pattern is 
shown in rig. 17a. Three peaks were clearly seen 
and./ 
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FIG.17. DISTRIBUTION PATTERN FOR EXTRACTS OF URINE. 










and the contents of the tubes shown below were 





Tubes 9 -38 
Tubes 39 -52 
Tubes 53 -80 
Weight 572 mg. 
Weight 232 mg. 
Weight 369 mg. 
Distribution of the ketonic fraction. 
For this distribution the solvent mixture 
ethanol water :cy clohe;ane:ethyl acetate 3:7:8:2 
was employed. In this system the partition 
coefficient of dehydroeoiandrosterone is approxi- 
mately 12; it is not possible to arrive at a more 
accurate value from the nomograms of Engel et al. 
(1954). The ketonic fraction was dissolved in 
40 ml. of the lower phase and placed in tube 0 
of the machine. After completion of the funda- 
mental procedure 100 fractions were collected by 
the single withdrawal method. These fractions 
were evaporated to dryness in a stream of air, 
the residues dissolved in 2 ml. of methanol and 
1/200 of each alternate fraction used for the 
Pettenkofer reaction. The Pettenkofer reaction 
was also performed on 0.2 ml. of each phase from 
alternate tubes of the counter- current apparatus. 
The/ 
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The distribution pattern is shown in Fig. 17b. 
Only two peaks were found one of which (number 4) 
moved almost with the solvent front. 
Identification of the material in peak 3 of the 
non - ketonic fraction. 
Due to the large amount of pigment present 
this fraction could not be induced to crystallize. 
It was therefore chromatographed on a 30 x 2 cm. 
column of Celite using 70¡ aqueous methanol (0.5 
ml. per g. of Celite) as stationary phase and 
petroleum ether (boiling range 80- 100 °C.) as 
mobile phase. Little material was eluted by the 
petroleum ether so the column was washed with 
methanol and the residue obtained from the methano 
washings rechromatographed on Celite using the 
solvent mixture benzene :70% aqueous methanol. 
Thirty three fractions each of 25 ml. were 
collected and the column was then washed with 
methanol. Crystalline material was obtained from 
fractions 5 to 11 and from fractions 23 to 29 but 
these have not yet been investigated further. 
Gashing the column with methanol eluted a large 
amount of crystalline material. This was filtered 
in methanol and evaporation of the methanol left 
a/ 
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a white residue weighing 53 mg. This residue was 
sparingly soluble in methanol and behaved in a 
similar manner to androst- 5- ene- 3p:16a:17¿- triol. 
The material was crystallized twice from methanol 
to give 15 mg. of slightly pigmented crystals 
which melted from 250 °C. to 257 °C. Since the 
crystals were still obviously impure they were 
acetylated and the increase in weight on acety- 
lati on was 5.5 mg. Thus the 
Increase in wt. on acctelation = 5.5 x l04 
of u.ña.cetylated compound l5 
= 36.7 
Assuming the material to be androst -5- ene- 3(; :16a: 
17ç -triol whose molecular weight is 306 
Increase in wt. on ace ylati_on = 126 
P Wt. of unacetylated compound 306 
= 41.2 
The triacetate was crystallized once from 
methanol and once from 95; ethanol and the tri- 
acetate melted from 180 to 183 °C. The melting 
point was not depressed when the triacetate was 
mixed with authenti c 3k;:16a:17p-triacetoxy- 
androst- 5 -sne. The presence of a 5-en-3p-ol 
group was indicated by the positive Pettenkofer 
reaction. It seems certain therefore that one 
component/ 
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component of peak 3 was androst -5- ene- 3p :16a;17p- 
triol. 
This isolation of androst-5-ene-3ç;16a;17p- 
triol has already been commented upon in the 
Discussion of Part I of this thesis. Since there 
is no evidence that the compound is present in 
the free state in urine it seems reasonable to 
conclude from the isolation above that it is 
present in urine as the 3p- sulphate. In a case 
of adrenal cortical tumour where the excretion of 
androst- 5- ene- 3p:16a :17p -triol was greatly in- 
creased Hirsclmiann (1943) could not extract any 
of the compound from urine with ether prior to 
acid hydrolysis. 
The material in peak 2 of the non ketonic 
fraction has not yet been investigated. When the 
material from peak 1 of the non ketonic fraction 
was chromatographed on Celite using the solvent 
mixture benzene :80 ;! aqueous methanol crystalline 
material was found in the first three fractions of 
eluate. These fractions were deeply pigmented 
and have not yet been investigated further. 
Washing the column with methanol eluted a large 
amount/ 
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amount of crystalline material which was deeply 
pipánented. This material was leached twice with 
0.5 ml. of methanol to remove the pigment and the 
white powder obtained (wt. 55 mg.) was crystalliz 
once from methanol and once from 80% aqueous 
ethanol. The melting point of the crystals 
obtained was 258 -260 °C. The nature of this com- 
pound is not yet known. From its chroulatographic 
behaviour and its appearance in the non- letonic 
fraction it is possible that it contains three 
hydroxyl groups. 
Identification of the material in peak 5 of the 
ketonic fraction. 
The residues contained in the tubes 
corresponding to transfer numbers 110 to 124 
inclusive were combined and leached with 0.5 ml. 
of methanol. This leaching removed most of the 
pigment leaving a mass of pale yellow crystals. 
These were dissolved in methanol, the solution 
filtered and the material obtained from evapor- 
ation of the methanol crystallized from methanol 
at room temperature. The melting point of the 
white needles obtained 
136 °C. i4elted 
138° Partial resolidification 
144° Beginning to melt again 





It was expected from its position in the 
distribution and from the large amount of it 
present that this material would be dehydroepi- 
androsterone. From the equation of Craig and 
Craig (1950):- 
N = K+l 
nK 
where N = tube containing the maximum amount of 
the solute 
n = number of transfers employed in the 
distribution 
and K = the partition coefficient 
we can calculate the position of the peak 
concentration of dehydroepiandrosterone. The 
partition coefficient for dehydroepiandrosterone 
in the solvent mixture used was approximately 12 
and n = 199 so that N = 185. Thus the peak 
concentration of dehydroepiandrosterone should 
appear in the tube corresponding to transfer 
number 115. From Fig. 17b it is seen that the 
peak concentration occurred in the tube corres- 
ponding to transfer number 113. The positive 
Pettenkofer reaction suggested that the compound 
possessed the 5- en -3p -ol group. The melting 
point of the isolated material was not depressed 
by admixture with pure dehydroepiandrosterone. 
Thus/ 
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Thus there can be little doubt that the material 
isolated was dehydroepiandrosterone. 
The material in peak 4 of the ketonic 
fraction has not yet been investigated. It is 
likely however to be a mixture of substances. One 
component will probably be K3 which has previously 
been isolated in small amounts in Part I of this 
thesis and which could be the 3p-chloro-derivative 
of K2. It is probable also that this peak will 
contain 3¡.- chloro- androst- 5 -en -17 -one. 
-191- 
APPETi DIX II. Tables 1, 2 and 14. 

















5a-androst-l6-en-3a-ol 144-145.5 +20.9 C 132-132.5 +20,5 E 
3ß-chloro-androst-5-en-17-one 156-158 +15.5 C - - 
3ß-chloro-androst-5-en-17ß-ol T 165-168 185-187 
5a- androst -l- ene -3:17 -dione 138 -142 +122 C - - 299 
230 
Androst -4- ene -3:17 -dione T.H 170 -171.5 +196 E - - 294 
235 
5a-androstane-3:17-dione 132-134 +112 E - - 302 
250 
5ß-androstane-3:17-dione 130-131 +112 E - - 302 
250 
3ß -hydroxy-androst-5-en-17-one 139,147- +12 E 168-169 +4 E 304,404,482 
(Déhydroepiandrosterone) 149 250,344,456 





187-187.5 +136 E 









en-17-one 169 -170 +151 A 
3(3 :17P-dihydroxy-androst- 
5-ene T 176 -178 -56 E 158-160 -54 E 240,307,404,482 
233,255,348,472 
440,540 
5¡3-androstane-3a:17ß-diol 233 -235 +26 125-127 343 
250 
3a-hydroxy-5a-androstan-17-one 184 -185 +97.7 E 160-162 +98.4 E 310,402,480 
(Androsterone) 258, 385,455 
331 
3a-hydroxy-5ß-androstan-17-one 143 -144, +111 E 92-93.5 311,409,500 
(Etiocholanolone) 150 259,389,452 
332 
3ß-hydroxy-5a-androstan-17-one 175 -176 +82 M 113-115 +69 C 310,407,490 
(epiA.ndrosterone) 252,389,450 
331 
3ß-hydroxy-5E3-androstan-17-one 154 -155 +89 C 155-158 
3ß -hydr oxy-andr os t-5-en-7 :17- 245 -248 -66.4 M 184.5- -72E 
di one H. T 187.5 
Table 1. contd. 
Steroid Melting [a -1D Melting MD H2 SO4 Chromogen point point 
acetate acetate 




11:17-dione 153.5-155 +127 E 183.5- +113 E 
184.5 
3a-hydroxy-5ß-androstane- 188-189 +95.8 E 163-164 +145.4 E 321,401 
11:17-dione 265,353 
238,380,412 
3a:11ß-dihydroxy-5a-androstan- 199-200 +98.4 E 240-242 +90.4 A 
17-one H 
3a:110-dihydroxy-5ß-androstan- 237-238 +104 D 238 341,402 
17-one H.T 266,371 
230,332 
3a:17ß-dihydroxy-5ß-androstan- 262-262.5 +68.4 E 182- +46.9 C 
11-one 18305 
3ß:16a:17ß-trihydroxy-androst- 264-266 -88 D 184-185 -102 E 380,415,470 
5-ene 240,395,435 
270,310 
3a:16a:17ß-trihydroxy-5a- 254-256 -5.9 M 
androstane 
3a:16a:17ß-trihydroxy-5ß- 274-278 +1.9 E 143- +43.5 E 
androstane 144.5 












112804 Chr omo gen 
5a-pregnane-3:20-dione 199-200 +117 E 
5P-pregnane-3:20-dione H 120-122 +112 C - - 237 (I) 
3a-hydroxy-pregn-16-en-20-one H, . 
3a-hydroxy-5a-pregnan-20-one 174-175 +95.7 E 140-142 +112 E 
3a-hydroxy-5ß-pregnan-20-one 148.5-149.5 +106 E 94-97 235, 331, 
267 
3a-hydroxy-5ß-pregnan-17-iso- 
20-one 143-145 -38.9 E 154-157 
3P-hydroxy-5a-pregnan-20-one 194-195 +91.2 E 144-146 +77 C 234, 329,, 
228, 263 
316:20a-dihydroxy-pregn-5-ene T 184-185 -53.5 C 146-147 -56 C 
5a-pregnane-3a:20a-diol 248-248.5 +17 C 141.5-14205 +18.8 C 343,430 
256,391 
322,502 
5ß-pregnane-3a:20a-diol 236-238 +27 E 176.5-178 + 41 A 340, 431 
258, 389 
233, 323, 497 
5a-pregnane-3ß:20a-diol 211-212 + 23 C 161 -2 E 320, 420 
260, 380 
5ß-pregnane-3ß:20a-diol H 182 
Table 2 contd. 
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Steroid Melting a ~D Melting La]D H2804 Chromogen 
point point acetate 
acetate 
3a- hydroxy -5ß- pregnane- 174.5 -175 +111 E 134 -135 +135 C 319,401 
11:20 -dione 262, 350 
382, 414 
3G:17ä- dihydroxy- pregn --5- 
en--20 -one T 





3ß:4- dihydroxy -l7a- methyl- 293 -299 -105 C 273 -278 -101 D 
D -homo- androst- 5- en'-17 -one T 
3(3:21 -dihydroxy -pregn -5 -en- 
20 -one 









3a:6a-dihydroxy-5a-pregnan- 195-196 +105 E 155-156 +92.3 E 
20-one 
3a; 6a-dihydroxy-5G-pregnan- 192-194 +66.3 C 128-129 
20-one 
3G:6a-dihydroxy-5a-pregnan- 206-210 +99 C 102-104 +74.5 C 
20-one 
3a:20a-dihydroxy-50-pregnan- 214-217 +56.7 E 231-233 +56.7 E 
-11-one 











































3a:17a-dihydroxy-513-pregnane- 207 -208 +68.5 A. 208 -209 
11:20-dione 





3a:17a:20a-trihydroxy-5R- 191 -193 +19 A 225-226 












+239 D 283, 354, 415 
233, 323, 371 
401 
+84 A 
+195 A 241, 287, 331, 374, 
418,460 












H2 SO4 Chromogen 
Steroid 






214 -216 +60 E 205-206 +88 E 
53-pregnane-3a:17a:20:21- 
tetrol. 
116:21- dihydroxy- 18 -al- 112, 166 +152.2 A 21Ac +121.7 C 288 
pregn- 4-ene- 3:20 -dione 198-199 
(Aldosterone) 18Ac 
217-219 
17a:21-dihydroxy-33-pregnane- 233 -235 228 -230 +82 A 251, 270, 342, 421 
3:11:20-trione 248, 257, 292, 372 
(Dihydrocortisone) 233, 242 
17a:21-dihydroxy-pregn-4- 
ene-3:11:20-trione 







1113:17a:21-trihydroxy-pregn- 212 -215 +168E 220 -224 +152 A 237, 282, 393, 475 
4-ene-3:20-dione 229, 252, 352, 417 
(Cortisol) 
3a: 17a : 21- tr ihydr oxy-53 - 
pregnane-11:20-dione 

























3o.: 17a : 21- te trahydr oxy- 208-209 +34.2 E 214-216 +28 C 
51$-pregnan-ll-one 
(Cortolone) 
3a:17a:201$:21-tetrahydroxy- 260-261.5 +40 E 205-206 +87.3 C 
51$-pregnan-ll-one 
(ß-- Cortolone) 
51$-pregnane-3a:11(3:17a: 250.5-254 +23.7 E 168-170 0 C 
20a:21-pentol 
(Cortol) 
51$-pregnane-3a:111$:17a:201$: 262-264. 5 +33.3E 239, 414, 500 
21-pentol) 225, 323, 489 
(1$r- Cortol) 290, 360, 378, 446 
61$:111$:17a:21-tetrahydroxy- 
pregn-4-ene-3:20-dione 
239-241 +76 M 122-125 +76 M 
(61$-Hydroxycortisol) 
Abbreviations:- A = acetone, C = chloroform, D = dioxane, E = ethanol, M = methanol. 
H - urine obtained from patients with adrenal hyperplasia. 
T - do. do. do. carcinoma. 
In column 6 (H2SO4 chromogen using the method of Zaffaroni, 1950): - 
1st row shows position (mµ) of maxima. 
2nd row do. minima. 
3rd row do. inflections. 
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Table 14. Steroids containing a 5- en -3G -ol group, or artifacts derived from them, which 
have been isolated from urine. 
Steroid Source 
Dehydroepiandrosterone Urine - normal 
(1,2,3,4,5,6) 
(3ß -hydr oxy -andr os t -5- 
en -17 -one) 
Urine - adr. 
carcinoma 
(7,8,9,28) 






Urine - guinea 
{pa after ad- 
min. of androst- 
5 -en -33 :17(3 diol 
(6,12) 
(b) after 




































3ß- chloro- androst -5 -en- Urine - normal 156 -158 
17 -one (1,4,5,15) (9) 
Urine - adr. 
carcinoma 
(8,9,16,28) 
Urine - adr. 
hyperplasia 
(10) 
Urine - after 
admin. of 
androst -5 -en- 
3ß : l7ß -diol 
(6) 
Androst -3:5 -dien- Urine - normal 
17 -one (4) 




3:5- cycloandrostan- Urine - normal 
6P-o1 -17 -one (18) 
(i- Androstanolone) 
















Table 14 contd. 
Steroid 
Androst -5- ene -3R :1713 - 
diol 
Source 
Urine - adr. 
carcinoma 
(16,21,22,28) 
Urine - after 









3(3- chloro- androst -5- Urine - after 165 -168 




5- ene -7:17 -dione 





















Spectrum of sulphuric 
acid solution 
-55.8 E Max.:240,307,404,482 
(26) Min.:233,255,348,472 






245 -248 -66.4 M 184.5- -72E 
(29) (29) 187.5 (29) 
(29) 




3ß:16a:17ß -trihydroxy- Urine - normal 265 -270 





Urine - adr. 
tumour 
(16,31,32) 















































Infl. : 270, 310 
(14) 
Table 14 contd. 
Steroid Source 
3ß:17a- dihydroxy- pregn- Urine - adr. 
5 -en -20 -one tumour (9) 
33: 17aa- dihydroxy- 
17 aß -methyl -D- 
homoandrost-5-en - 
17-one 
Urine - adr. 
tumour (9) 
30:16a:20a- t?ihydroxy- Urine - adr. 











234 -235 -40.9 D 
(39) (39) 
17- acetate 





180 -182 -64.9 D 
(40) (40) 
302 -305 -110 D 277-279 -101 D 
(42) (42) (40) (42) 
245 -248 





178.5-180 -101 E 
(38) (38) 
Spectrum of sulphuric 
acid solution 
Max. : 310, 410, 495 
Min. : 365 , 46 0 
(33) 
Table 14 contd. 
Steroid Source 
5ß:17a:20a- trihydroxy- Urine - adr. 

























161 -162 +192 E 
(46) +182 C 
(46) 
Diacetate 
165-166 +28 C 
(47) (47) 
Abbreviations:. A = acetone, C = chloroform, D = dioxane, E = ethanol M = methanol 





Inf 1. 314,533 
(27) 
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